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CHAPTER ONE: INTRODUCTION
The pathogenesis and uncertain heterogeneous etiology of liver disease and
subsequent failure have led to increased patient morbidity/mortality rates and still represent
a steadfast socio-economic burden in most developed and underdeveloped countries. Liver
failure presents itself in many ways (i.e. chronic failure, acute failure, acute-to-chronic etc.)
and is estimated to cause 9.4 deaths per 100, 000 US citizens annually. Going forward, acute
liver/hepatic failure will be given precedence in this segment because the need for
transplantation is of the essence and failure rates post-transplantation are considerably lower
than chronic or acute-to-chronic incidences [1].
Acute hepatic failure (AHF) is an aggressive, unpredictable clinical syndrome that is
hallmarked by the loss of homeostatic functionality when the rate of hepatic death supersedes
that of hepatic regeneration [2] not the inability to regenerate hepatocytes [3]. AHF provokes
hepatic necrosis, apoptosis or necrapoptisis [4] which leads to catastrophic conditions such
as coagulopathy, circulation dysfunction, encephalopathy, cerebral edema, coma and
possible death via multi-organ failure [5]. It is estimated that AHF will affect more than 2800
and 500 in the United States and United Kingdom respectively. In the adult community, AHF
is manifested by viral hepatitis or drug induced hepatotoxicity [6]. The issue is more critical
in the neonatal and pediatric age group, where hepatic decomposition is attributed to prenatal
infections, hypotension/shock, hematological malignancies, infectious hepatitis, immune
disregulation and inborn metabolic disorders [7]. Although prognosis varies with etiology, in
terms of mortality, 90% is noted for adults [8], 74% for children [9] and 70% for neonates [7].
Absent a pre-existing pathosis, recovery is attainable in acute hepatic failure if: (a)
functionality is sufficiently replaced; (b) the liver’s regenerative competency is preserved; (c)
and the pathogenic factor is abated or rendered quiescent [10]. Unfortunately, resolution for
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end-stage hepatic failure patients lies solely in orthotopic liver transplantation. In the United
States more than 14,110 adults and 2,490 children await a suitable transplant organs [11],
with numbers compounding at rates of 20% to 30% annually [12]. The dilemma of organ
shortages is also aggravated by the fact that cadaver organ availability has only increased by
2% to 3% per year [12]. This is exacerbated by pre-transplant concerns such as “small-forsize” or “large-for-size” syndrome [13] and post-transplant complications like acute graft
rejection, liver abscesses, adrenal gland hemorrhage, lymphoproliferative disorders[14] and
chronic immuno-suppression therapy, which can heighten liver and kidney damage and lead
to increased susceptibility to viral infections in the pediatric age group [15].
In spite of the significant advances in medicinal therapies, donor pool expansion
techniques and extracorporeal support systems, a viable cure for acute failure still plagues
the scientific community. To combat this shortfall, concerted research efforts have focused
on the field of tissue engineering. It is believed that in its fruition, the field will yield an “off the
shelf”, reliable modality or at best a countermeasure that will retard the progression of the
hepatic pathosis.

To this end, it is imperative that the future focus shifts to how the

independent and synergistic function of parenchymal and nonparenchymal cells, in
conjunction with how external and internal environmental stimuli influence their interactions
and downstream cellular processes.
The lack of an effective therapy for liver diseases in conjunction with the need for
healthy donor livers and reliable donor pool expansion techniques has fueled the race for
transplantable tissue engineered analogues. The actualization of a neo-organ fashioned from
isolated liver cells (hepatocytes) would have positive medicinal ramifications for patients
suffering from acute liver failure (ALF), acute-to-chronic liver failure and inborn enzyme and
metabolic diseases.

This realization would also increase the off-shelf availability of

transplantable organs in concert with creating a definitive donor pool expansion technique.
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However the fruition of a functional hepatic tissue engineered modality is hampered by
deficient long-term endogenous phenotypic expression and cell viability. More specifically,
major limitations are seen in the areas of transport (e.g. oxygen supply and tension, nutrient
and waste exchange) and the accurate characterization of the fluid dynamic microenvironment within hepatocyte impregnated three dimensional scaffolds.
The primary hypothesis of this body of work is that direct and sustained physiological
oxygenation in conjunction with a perfused aqueous oxygen supply within a three dimensional
milieu will ensure short-to-medium term cell viability while encouraging suitable liver specific
functionality. In order to investigate this hypothesis chitosan scaffolds were fabricated as a
cylindrical, three dimensional tube with embedded gas-permeable silicone tubing to simulate
in vivo capillary gas exchange. The metrics employed to evaluate the efficacy of this model
were nuclear viability staining, albumin production and ureagenesis.
We utilized a computational fluid dynamic (CFD) model to accurately characterize and
understand the shear stresses that were imposed on the hepatocytes within the micro-porous
scaffold environment. This CFD model was used to identify which culture medium flow rates
imposed the least amount of damage caused by hydrodynamic forces, while still allowing for
adequate convective flow throughout the scaffold’s spatial geometry. The flow rates used in
the CFD model were also investigated using an in-vitro perfusion bioreactor system in
conjunction with our three dimensional, hepatocyte-seeded scaffold.
Lastly, we investigated the effects of altering the scaffold’s geometry in an attempt to
increase the hepatocyte packing density and encourage cellular aggregation.

We

hypothesize that by creating a micro-environment that promotes cellular aggregation we
would see enhanced cell-to-cell and cell-to-substratum contact throughout the scaffold
interior, thus positively modulating hepatic functionality and restoring the cells to their
phenotypic differentiated state.
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The specific aims for this study were:
1) Design and assemble a perfusion bioreactor system with integrated direct oxygenation
capabilities suitable for maintaining in vitro hepatocyte single cell and spheroid
cultures.
2) Compare the effects that aqueous oxygenation versus aqueous+direct oxygenation
have on hepatocyte metabolism and differentiated state.
3) Develop a computer-generated computational fluid dynamics (CFD) model to
understand the internal scaffold flow characteristics and the micro shear environment
at various flow rates. We would also use this model to assess how these flow rates
affect hepatocyte oxygen uptake kinetics along the length of the scaffold.
4) Validate the aforementioned flow rates mentioned in specific aim three with our
perfusion bioreactor system to assess which rates corresponded best with the CFD
data and positively influenced hepatic differentiated activities.
5) Evaluate the effects of reducing the scaffold’s volume and increasing seeding
densities have on albumin production, ureagenesis, viability and aggregate
morphology. .
The remainder of the dissertation is organized as follows: Chapter two reviews the
background and significance of the liver’s anatomy, physiology and pathogenesis. It also
explains the importance of hepatocytes and the role they play in maintaining homeostasis,
the modes of hepatic failure and the various in-use and exploratory methods that are being
employed to restore function after it has been compromised.

Chapter three reports the

effects that aqueous plus direct oxygenation have on hepatic differentiated functionality in a
three dimensional chitosan scaffold perfusion bioreactor model. These results are also
compared to a perfusion bioreactor model that utilizes the same model less direct
oxygenation.

Additionally, we looked at how this three dimensional perfusion model
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modulated albumin protein expression, ureagenesis, aggregate morphology and viability.
Chapter four reports the results of our computational fluid dynamic (CFD) model that
investigated the hydrodynamic forces imposed on the hepatocytes imbedded in our chitosan
scaffold at various flow rates. The CFD model also aided in elucidating the fluid flow and
oxygen uptake characteristics within the cell-seeded scaffold environment. Chapter five is
devoted to validating the flow rates used in the CFD model (chapter four) and assessing the
effects of these rates on hepatic function. In addition to functionality, we also examined how
these flow rates affected hepatocyte viability. Chapter six looks at how changing the spatial
geometry of the scaffold modulated functionality, hepatocyte morphology and viability. Each
chapter provides a background for the research objectives, explains the methodology and
material utilized to conduct the experiments, describes results and summarizes these results
in a discussion segment.
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CHAPTER TWO: LITERATURE REVIEW
2.1

Liver Anatomy, Physiology and Pathogenesis
The liver is a complex, highly vascularized bio-ecological system. It achieves

homeostasis through the harmonious orchestration of multiple metabolic interactions,
numerous cytokine networks and the co-interplay of its cellular constituents and matrix
components [16, 17]. Situated under the diaphragm, the liver consists of two major lobes that
are further segregated into smaller units.

The strategic position (i.e. between the

gastrointestinal tract and systemic circulation) of the liver allows receivership of venous blood
from multiple sources. Therefore the liver is able to regulate the concentration of incoming
hormones, toxins and lipophilic and hydrophilic nutrients in the terminal hepatic venules
through various endocrine functions. By this it is able to efficiently function as an effector and
sensor organ [18] table 1. In addition to its endocrine activity, the liver also exhibits exocrine
functionality.
The intricate spatial orientation of the liver’s cellular architecture is considered a
histological homogenous structure; however this notion is contrasted by its morphometric and
histochemical heterogeneity.

This heterogeneity stems from the zonal (periportal and

centrolobular) and regional (septal and portal) variances in subcellular structural features,
metabolic capacities of the cellular elements, substrate concentrations and hormone levels
[19].

Cellular heterogeneity is also facilitated by varying cell receptors and their

corresponding densities and dynamic gradients (oxygen, biomatrix etc.) that are established
between the upstream and downstream segments of the hepatic sinusoid [18].
2.2

Hepatic Extracellular Matrix (ECM)
The hepatic extracellular matrices (ECM) are insoluble structures that constitute the

reticulin framework of the liver. Restricted to the portal tracts, sinusoid walls and the central
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veins the hepatic ECM composition encompasses three distinct classes of macromolecules:
collagens, non-collagenous glycoproteins and proteoglycans [20]. In addition the liver ECM
is composed of water, electrolytes and trace flow-through elements which constitute its minor
constituents [21]. Its architecture is distinct from other epithelial organs in that it lacks
extensive areas of connective tissue and a cell separating basement membrane. Moreover
it carries a strategic location and function: It acts as a reduced permeability demarcation
between the portal blood plasma and the parenchyma; and aids in the bidirectional exchange
of macromolecules between hepatocytes and circulating blood [22].
The main functions of the hepatic ECM are similar to its epithelial organ counterparts
in that it allows intercellular communication, cohesiveness between cells and provides a
structural framework [23, 24]. More specifically through positional, locomotive, growth, and
differentiation-promoting signals, the hepatic ECM is able to regulate parenchymal and nonparenchymal function, gene expression, differentiation, proliferation, cell polarity and
apoptosis [25]. Moreover the insolubility of the hepatic ECM allows it to exert influences over
cellular activities at short range and in tight spatially controlled fashions [26]. Furthermore,
the dynamic aspects of matrix degradation (via Metalloproteinases) and zonal gradients
formed by its macromolecular components also contribute to the modulation of hepatic
function [18, 27, 28].
2.3

Hepatocytes
Hepatocytes are large polyhedral epithelial intermediate cells that spawn from

endodermal foregut precursor cells [29]. Analogous to other epithelial cells, hepatoctyes are
highly polarized; and accounts for 60% of the cell population and 80% of the organ volume
[30]. Structurally, hepatocytes are between 30 to 40µm in diameter, organized in unicellular
muralium that bifurcate and anastomose to form an intricate network with limiting plates at
the capsule and portal regions [31].
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Anatomically, the hepatocyte contains three main domains: Basolateral domain,
Apical or Cannicular and the Laterl domain which account for 70%, 15% and 15% of the total
cell surface area respectively [32] . The cytoskeleton of the hepatocyte and the maintenance
of its overall integrity are paramount to hepatic-specific functionality. The cytoskeleton is
composed of many different proteins that assist in overall cell health, however the major
components that are germane to this effort are microfilaments, microtubules and intermediate
filaments [33]. Briefly Microfilaments are responsible for cell membrane motility, endocytosis,
exocytosis and vesicle transfer. Microtubules are mainly involved with the secretion of vital
liver-specific functional products such as albumin, fibrinogen and numerous glycoproteins
[31]. Lastly are intermediate filaments (cytokeratins) act as intracellular scaffolds in areas
where mechanical stress is prevalent. Furthermore they are associate with maintaining
structural polarity within the hepatocyte and providing a framework for actin distribution
endocytotic vesicles along the plasma membrane [34]. When assessed independently these
structures are chemically and functionally distinct, however when working in conjunction, they
are responsible for the modulation and functional demands of the hepatocyte in response to
various external and intercellular stimuli.
The complexity of the liver also stems from the thousands of vital homeostatic
operations performed by its main parenchymal functional unit. As the workhorse of the liver,
hepatocytes

are

responsible

for

a

myriad

of

metabolic

processes,

xenobiotic

biotransformation, bile production and liver transcriptome (i.e. genes expressed as measured
by mRNA) [30]. Such activities are influenced by the hepatocytes high rate of oxygen
consumption and its ability to produce and regulate its energy reserves.
Zonation or compartmentalization of gene expression, morphology and function exist
within the hepatic acinus. Hepatic zonation is determined by oxygen, substrate/extracellular
matrix protein distribution and hormone gradients between the periportal and perivenous
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areas [35]. Hepatocellular zonation results in parenchymal heterogeneity with respect to
infrastructure, ultrastructure and protein activity. This complex aspect is exacerbated by the
fact that zonal heterogeneity is dynamic and is subject to change based on the level of hepatic
pathos or its current metabolic status [19].
2.4

Hepatocyte Cell Junctions
The hepatocytes ability to remain in a homeostatic state is overwhelming modulated

by its ability to maintain vital interactions with its adjacent environment. Such interactions,
which are mediated by both nonjunctional and junctional mechanisms, include cell-to-cell and
cell-to-extracellular matrix contacts. The presence and adequate maintenance of these
junctional mediated interactions that are critical for hepatic-specific functions including
albumin secretion, ammonia detoxification, glycogenolysis and bile secretion [36].

Gap

junctions are a specialized group of intracellular channels that provide a pathway for
intracellular communication between adjacent hepatoytes, participates in all aspects of the
cell cycle and aids in hepatic homeostasis [37]. Tight junctions specialize in sealing adjacent
epithelial cells together, but also form a much regulated tissue space divide that contributes
to the maintenance of tissue integrity. Tight junctions are also known to play a critical role in
cellular interaction and intra-actions (i.e. signal transduction, transcriptional regulation and
cell cycle [38]), communication and modulate the movement of selective paracellular solutes
across the epithelium [39].

The in-vivo cellular plate architecture of the liver relies

tremendously on these junctions as they maintain polarity by demarcating the hepatic apical
surface from the basolateral surface which in turn ensures adequate bile secretion and the
removal of xenobiotic agents [40]. Integrins are a class of adhesion molecules in which
hepatocytes utilize to adhere to their ECM or basement membranes.

The adhesion

receptors/ECM interactions help to maintain basal-apical polarity, tissue integrity and cellular
architecture [41]. In vivo, the type of integrin expression is dependant on the constituents of
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the basement membrane and parenchyma zonal location [42]. However in vitro integrin
expression levels are strictly controlled by the type of cell-ECM interactions [43]. Integrins
activate intracellular signaling pathways or cascades in response to various extacellular
environmental cues. Intracellular proteins such as FAK and Erk aid in regulating migration,
and differentiation proliferation, and Rho in morphology [44, 45]. Additionally MAPK and Akt
once activated by FAK are responsible for the suppression of receptor/ECM detachment
based apoptosis (Anoikis) [46].
2.5

Liver Oxygen Tensions
As the metabolic epicenter for the human body, the liver is responsible for regulating

numerous functions. Such functions include but are not limited to carbohydrate, amino acid
and fatty acid metabolism, bile secretion and detoxification, which are orchestrated by the
hepatic parenchymal cells [47]. Because of such a heavy physiological burden, adequate
oxygen consumption under strict hepatic zonal pO2 is critical to maintaining the liver
microenvironment. The hepatocyte relies on over 1500 mitochondria for energy production
and consumes oxygen at a rate of .3 to .9nmol/sec/106 cells [48]. As mentioned earlier the
liver is zonal is nature with regulated oxygen tension for each zone.

The zones and

corresponding oxygen tension ranges are as follows: periportal – 60 to 65 mmHg (84 – 91
µmol/L), perivenous – 30 to 35 mmHg (42 – 49 µmol/L) [49].
2.6

Modes of Liver Failure
Several factors have been identified that trigger the intrinsic and or extrinsic pathways

that contribute to cellular death. Such factors include hypoxia, reactive oxygen species,
toxins and various immune processes. Cellular death can be categorized by either apoptosis
or necrosis. Necrosis, also known as oncotic necrosis or oncosis, is considered a passive
form of cell death that is a consequence of some form of acute metabolic perturbation or
acute drug induced hepatotoxicity.

It leads to oxygen deprivation and subsequent ROS
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generation and mitochondrial dysfunction [50]. Apoptosis, conversely, is programmed cell
death that initiated by intrinsic mechanisms that are regulated by various signaling pathways.
This mode of death leads to cellular resorption which mitigates inflammatory responses and
leakage of cellular constituents into the extracellular space [51]. Autophagy is lysosomal
catabolic pathway that is characterized by the degradation of cytosolic proteins and
organelles. It is induced during starvation and promotes survival by providing amino acids
and participating in glucose metabolism. However in cases of prolonged starvation acute
liver insufficiencies occur which triggers autohpagic cell death [52].
2.7

Treatment of Acute Liver Failure

2.7.1 Surgical Based Approaches
Split Liver Transplantation
As previously stated orthotopic liver transplantation is the gold standard of treatment.
However suitable organs for transplantation are the limiting common denominator. Due to
this shortening of cadaveric organs, donor pool expansion techniques such as split liver
transplantation have been employed. The protocol has reported results similar to whole liver
transplantation. However the procedure many be complicated by complicated by anatomical
variations. Furthermore, lack of availability has led to the use of marginal to sub-par quality
organs [53].
Living Donor Transplantation
Comparable to split liver transplantation, living donor transplantation has also been
used with the intent of ameliorating the organ shortage crisis. Living donor transplantation
takes advantage of the right lobe in the case of adult patients and the left for adolescents.
Due to the complexity associated with a lobectomy procedure, donors are predisposed to
great health risks. Again, the lack of availability has compromised selection criteria, allowing
ailing and elderly individuals to become candidates [54].
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2.7.2 Non-Biological Approach
Hemofiltration/Hemodialysis
Hemodialysis was introduced with the intent of efficient hepato-toxin removal by way
of diffusion, but offered little in this way as an effective filtering measure of small water soluble
molecules with molecular weights less than 5000.

Driven by convection, hemofiltration

offered a higher competence for filtration as it extracted middle molecular weight compounds
ranging from 5000 to 10000 [55]. In addition to hemofiltration’s inability to eradicate lipophilic
or protein bond substances [56], it also lacks specificity in its abstraction of low and medium
molecular weight substances. Both methods used concomitantly, coined hemodiafiltration,
demonstrated improved biochemical parameters and neurological status, but had little effect
on patient survival rates [57]. Dialysis circuits are also known to induce a range of biological
effects such as production of endogenous monocytic pyrogens [58], heightened levels of
superoxides, IL-6, IL-1, TNF-α and C3a/C5a via complement cascade activation. However,
little is known of the effects that dialysis has on the mitogens EGF and HGF [59].
Hemoperfusion
Hemoperfusion describes the aggressive removal of protein bound toxic molecules
via blood circulation over sorbent materials such as activated charcoals, anion exchange
resins or synthetic neutral resins.

In addition to the decline in fibrinogen levels, deleterious

effects stemmed from the bio-incompatibility between blood and the extracorporeal circuit,
resulting in leukopaenia, removal of coagulation factors and activation of the complement
cascade [60].
Despite countermeasures used to mitigate foreign body reactions such as
biocompatible polymer coatings [61] and encapsulants, the nonspecific targeting of molecules
of varying molecular weights and chemical characteristics remained a challenge. During
hemoperfusion charcoal absorbents exhibited complete removal of hormones and growth
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factors [62-65] critical to hepatic regeneration whereas platelet and leucocyte counts were
diminished with resins [60].

When coupled with albumin dialysis (Hemodiabsorbtion),

cytokines IL-6 and TNF-α [60], in addition to substances with high albumin affinity were
abated [62]. The elucidation of the effect that this technology has on the removal of mitogens
EGF and HGF is still unclear.
Plasma Exchange
Plasma exchange essentially is a technique of separating plasma from the patient’s
cellular blood component via plasmapheresis and exchanging it with an equivalent volume of
fresh frozen plasma from a healthy donor. The method’s aim is to suppress symptoms of
hepatic failure by removal of circulating toxins and waste products to promote an environment
that is conducive to liver recovery or regeneration. Although this method has shown
improvement in hemodynamic stability [66], coagulation profiles and cerebral function,
adverse effects such as coagulation imbalance, citrate load [67, 68], toxic effect, infection and
pulmonary and neurological complications are noted [59]. Other faults experienced by this
therapy is the non-selective manner in which it abates or reduces potentially helpful
substances that could contribute to hepatic convalescence[69] and its ineffectiveness in
decreasing the large intracellular pool of hepatoxins that accumulate during liver failure.
These factors in conjunction with the need for high volumes of replacement plasma and cost
have restricted its use.
Albumin Dialysis
Considered the most proficient non-biological modality, albumin dialysis combines the
detoxification of water-soluble and protein-bound toxins in a recirculating closed-loop albumin
circuit.

To date, Molecular Adsorbents Recirculating System (MARS) is the most

comprehensively assessed dialysis system. MARS incorporates a two-fold passive transport
sequence allowing a down-stream diffusion of toxins from the plasma to the free binding sites
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of the membrane and secondly, from the membrane to the free binding sites of the dialysate.
The dialysate is filtered via anion exchange chromatography, charcoal filtration and
sequential dialysis. The system likewise allows non-albumin bound, low molecular weight,
water soluble molecules to transgress the membrane [70].
2.7.3 Cell-Based Therapies
The complexity of the liver combined with the detoxificational, bio-transformational and
metabolic ineptness of current non-biological support systems have galvanized the efforts
towards the use of viable hepatocytes as a means of perpetuating and regulating liver specific
functions. The ideology behind hybrid bioartificial liver support systems is that liver-specific
functions can be re-established by hepatocytes in an exogenous milieu. To this, implantation
techniques, systems and extracorporeal devices have been developed to cultivate this ideal.
Extracorporeal Whole Liver Perfusion (ECLP)
This method involves perfusing a patient’s blood through a xenogeneic or allogeneic
liver. ECLP has been proven to support ALF patients for several days [71], however it is
considered impractical due its association with xenogenic immuno-complexes. Nonetheless
transgenic porcine livers (TPL) have been used in attempts to overcome the potential
immunological barriers posed by its predecessors. Clinically, patients treated via ECLP-TPL
showed no symptoms of porcine endogenous retrovirus (PERV) infection [72]. Moreover,
preclinical baboon and ex-vivo xeno-perfusion models have garnered promise, showing
reduced complement activation and superior histology [73-75]. Still more clinical trials are
needed to explicate the potential for high xeno-protein influx and transferal of other zoonosis.
Cellular Implantation
Cellular implantation attained favor because it is simpler, less invasive, cost-effective
and fewer cells are needed to sustain life. The intrinsic micro-environment of the liver was
sought as the primary site to foster engraftment and functionality. However this led to severe
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hypertension and hepatic necrosis due to aggregate formation and thrombi in distal portal
branches, sinusoids and central veins [76, 77]. Various ectopic sites have also been explored
e.g. peritoneum, lungs, fat pads, pancreas, mesenteric leaves, under the kidney capsule and
subcutaneous tissues [78-80] but only the spleen has shown potential [81]. In addition, a
liver-specific architecture, basement substratum and venous supply that encompasses the
mechanical and biochemical environment of the hepatic sinusoid was lacking [82].
To enhance functionality, advanced systems using microcarrier beads, spheroid
aggregates and biodegradable polymeric immobilization substances have been employed.
In addition angiogenic agents have been employed with success to pre-transplant sites, but
have been deemed beneficial only for metabolic disorders not ALF [80]. To date, the main
disadvantages in using implanted hepatocytes are the delay of function upon implantation
and the lack of proliferation without sufficient growth factors [83].
“Hepatocyte repopulation” has recently stimulated endeavors at improving the
efficiency of cell engraftment and propagation. The goal of hepatocyte repopulation is a
coordinated process of cell replacement in which exogenous cells are used to replenish the
liver mass to its original state and facilitate hepatic homeostasis. In order for this to occur
transplanted cells must have a growth and/or survival advantage over the damaged
population and their must be space in the recipient organ for these cells to grow [84].
Subsequent to engraftment, the fundamental mechanism entails clonal proliferative stimuli
induction and suppression of host cell mitosis [83]. Stimuli induction can come via loss of
hepatic mass, reperfusion injury, massive endogenous apoptosis mediated by Fas-gene
transfection or administration of hepatocellular mitotic stimulants [85]. The technology has
garnered success in rodent models [86], and is deemed plausible as a treatment for metabolic
disorders.
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Although this technique has promise, it does have some obvious short-comings.
Hepatocyte repopulation, in multiple models, has been shown to consistently and inherently
be linked to with an increased risk of cancer development in the liver. To date the reasons
why engrafted cells either produce normal versus cancerous liver histology has yet to be
elucidated. However these cancerous events are thought to stem from either a diminished
expression of gap junction protein connexin 32 and integrin protein IG-5-1, and the altered
expression of matrix metalloproteinases 2 (MMP2) [87]. To be seen as a permanent modality
for acute liver failure, more research and clinical trials are needed.
Extracorporeal Devices
The aforementioned modalities have resulted in the conception of the bioartificial liver
(BAL) or hybrid liver support device. This two prong method functions by maintaining cultured
immobilized hepatocytes (bio-component) in an exogenous bioreactor system (artificial
component), while temporarily integrated into the patient’s blood or plasma perfusion circuit.
The objective of the BAL system is to either stabilize and support patients prior to orthotopic
transplantation, act as a bridge for patients awaiting a suitable donor organ or operate as a
conduit for liver regeneration [88]. To date, BAL extracorporeal devices such as HepatAssist,
Extracorporeal Liver Assist Device (ELAD), Modular Extracorporeal Liver Support (MELSTM),
Bioartificial Liver Support System (BLSSTM) and the Amsterdam Medical Center Bioartificial
Liver (AMC-BALTM) have reached some level of clinical trial; however none have proven to
be completely effective in suppressing all the events associated with liver failure.
The most appropriate hepatic cell source for extracorporeal devices is primary human
hepatocytes. Theoretically, they provide all the necessary biological functions needed to
maintain homeostasis. However the limiting factor is availability, as most eligible donor
organs are used for transplantation [89]. Cryopreservation tactics were implemented to
mollify the burden of availability, but offered little value as calamitous effects (i.e. detachment,
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functional degradation, apoptotic and necrotic death) are induced by thawing [90, 91].
Moreover human hepatocytes are difficult to regenerate in vitro, are characterized by
heterogeneity and low viability, express inadequate levels of liver-specific functions due to
loss of gap junctions, originate from histologically impaired organs and pose complex
logistical concerns [5, 92, 93].
Immortalized hepatocyte cell lines such as C3A stemming from hepatoblastoma cell
lines have also been incorporated into support devices. Such cell lines hold a theorectical
advantages over primary cells in that they are not mitotically inactive and can proliferate
indefinitely, they secrete high albumin levels, but lack promise due to insufficient ureagenesis
and amino acid metabolism [94]. Moreover, these sources also pose concerns for high risk
transmission of potential tumorigenic cells [59, 95]. Adult and embryonic stem cells are
currently being pursued as a final alternative. The utilization of adult stem cells as a surrogate
has peaked the interest of many investigators, but the plasticity [96] and ability to efficiently
differentiate and proliferate these cells remains a formidable challenge [97].
Due to abundant available quantities and their ability to maintain a highly differentiated
state of functionality, primary porcine hepatocytes have been sought and used in the majority
of clinically applied BAL reactors. Unlike C3A cell lines, porcine based hepatocytes maintain
the necessary hepatocyte-specific function including but not limited to ammonia detoxification
[89]. Albeit the great optimism of this cell type, many unresolved obstacles plague its efficacy
in BAL systems. Foremost are the apprehensions regarding immunological complications
emanating from xenogeneic protein influx [98], tumorigenicity, and the transmission of viral
zoonoses, such as porcine endogenous retrovirus (PERV). Although no reports of human
cross infection have been reported in BAL therapy, the theoretical chance of transmission,
mutation and subsequent viral pathogenesis still looms [60, 99].
2.7.4 Tissue Engineered/Regenerative Medicine Constructs
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The emerging and rapidly advancing knowledge base of tissue engineering exploits
individual and mixed cell populations to create, restore, maintain, or enhance 3D tissues and
organs [100]. Similar to implantation, the science excels under the notion that cell-infused
exogenous implants can effectively replace diminished or non-existing function when placed
in vivo. To this, cells are explanted and coaxed to grow on (biological or synthetic) bio:
compatible, degradable and resorbable scaffolds which serve as a nano/micro-habitat for
cellular support.

In addition to support, it is vital that the construct’s architecture and

chemistry offer native tissue specific physio-chemical and mechanical cues that provide an
environment which is conducive to the correct activation of downstream signaling pathways
[101] and cell-to-substrate and cell-to-cell interactions.
More specifically, hepatic tissue engineering (HPT) focuses on creating an
implantable, fully functioning liver expedient. Drawing parallels to extracorporeal adjuncts,
HPT also makes use of various hepatic and nonparenchymal cell types, sources, spatial
configurations and in vitro bioreactor culturing configurations. Parallels are also seen in
promise and shortcomings. The promise is seen in the advances of culture techniques, shortterm hepatic-specific physiology and anatomy, growth factor combinations and material
modifications. However, HPT is hampered by issues pertaining to cell sourcing, co-culture
schema, immune rejection, long-term viability, sustainable phenotypic expression and
morphology, tissue reorganization and transport (i.e. nutrient, gas and waste) due to a lack
of a viable hepatic vasculature.
2.8

Hepatocytes – 2D Cell Culture to 3D Bioreactor Studies

2.8.1 2D Hepatocyte Cultures
Primary hepatocytes are highly differentiated, attachment dependent epithelial cells,
whose structural and functional integrity (i.e. phenotype) stems from regulatory interactions
between unique DNA binding sites and the patterned expression trans-acting protein factors.

19
The use of primary in vitro hepatocyte cell cultures has been the principal model for
elucidating the complexities of liver-specific functionality. Initial culture attempts utilized
conventional methods involving suspension and hepatic platting on rigid substratums (i.e.
plastic or ECM protein coated plates). Under such conservative conditions hepatocytes
exemplified enhanced attachment [102], high proliferation kinetic, short-terms liver specific
functionality [103] and in vivo-like cytoskeletal protein distribution and morphology [104].
However, as culture conditions progressed, drastic changes were observed in morphological
intactness and polarity [105-107], a rapid decline in liver-specific enzyme activity [108-110],
up-regulation of fetal and cytoskeletal proteins [111, 112] and sustained expression of protooncogenes [113].
The limitations displayed by conventional/simple substratum methodologies gave way
to improvements in the approach towards restoration and sustainability of a differentiated
hepatic phenotype.

Hepatocytes cultured in a hepatic micro-architecture mimicking

configuration (i.e. collagen gel sandwich) displayed sustained viability, competent liverspecific functionality and native-like morphology [114-116].

Furthermore, collagen gel

sandwich cultures induced hepatic gap junction formation, bile canalicular repolarization,
normal bile acid transportation [117-119], and xenobiotic biotransformation [120]. Likewise,
superior hepatic biochemical differentia is noted when hepatocytes are cultured on rat liver
membrane extracts [121, 122] and complex extracellular matrix materials: liver emanated
biomatrices [123-125] and mouse derived sarcoma tissue [114, 116, 126]. Lastly, heightened
levels of liver-specific functionality have also been noted when hepatocytes are cultured on
modified natural and or synthetic materials, as multi-cellular aggregates or with
nonparenchymal cells.
2.8.2 3D Implantable Porous Scaffolds and Perfusion Cultures

20
The fabrication of a synthetic liver organoid requires sustained cellular viability and
metabolic activity. Additionally, successful guided tissue regeneration must incorporate the
use of 3D highly porous matrices with an intrinsic network of interconnected channels that
have biodegradation and or bioresorption characteristics. In tandem, porous constructs and
dynamic perfusion systems have the advantage of producing an environment that mimics the
hepatic sinusoid flow circuit, facilitate a differentiated phenotype, enhance neovascularization
and elevate mass transport capacities. As well, cultures under continuous flow are more
sensitive to hormone induced tissue function and have shown to improve viability, lifespan,
metabolic output and vivo-like cellular reorganization. To this, the ideal scaffold and perfusion
reactor system should collectively control the following variables [127, 128]:
•

Accommodate high density seeding, uniform cell distribution, cell attachment, and
spatial cellular reorganization (Aggregates/Spheroids & Angiogenesis)

•

Promote efficient mass transfer of nutrients, gas mixture and nitrogenated waste,
to and from cells, via convective and diffusive flow

•

Regulate Oxygen tension, pH, temperature and pressure

•

Control medium flow rate, shear stress and hydrodynamic stimulation/suppression

•

Promote cellular adhesion and a sustainable differentiated phenotype

•

Minimize cellular washout

•

Facilitate the removal of acidic scaffold artifacts

•

Retain possible newly synthesized ECM components within construct

•

Prevent medium back mixing or recirculation between cellular constituents

The need to restore and protract hepatospecific functionalities and alleviate the
deleterious stimuli imposed on hepatocytes by an exogenous environment demands a
biphasic approach (i.e. Perfusion reactor, biodegradable/bioabsorbable polymer) that
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effectively recreates and mimics the in vivo micro-domain prior to reimplantation. Initial
studies that applied this scheme utilized synthetic Poly(D,L-lactic-co-glycolic acid) PLGA
scaffolds. Under short-term culture conditions, Kim et al. [129] accomplished successful cellsubstrate attachment, induce in vivo-like reaggregation and maintain a higher mean
concentration of albumin in comparison to static cultures. Similarly, Park [130] and Fiegel et
al. [131], used continuous flow conditions and PLGA augmented matrices to significantly
improve cell viability, function and morphology in contrast to unmodified, static and negative
control cultures. Likewise, biodegradable poly(L-lactic acid) (PLLA) with continuous flow
[132, 133] and pulsatile flow [134] was also able to prolong liver specific function and instigate
a cellular anatomy comparable to what is seen in vivo. In addition these physiochemical
parameters, Torok et al. [135] was able to conclude that this configuration also fostered
monoethylglycinexylidine (MEGX) expression, normal Cytokeratin 18 (CK18) distribution,
homogenous glycogen storage and, intercellular junction and bile canaliculi formation.
Analogous trends associated with cellular faculties, attachment and histological viability were
evident with biodegradable polyglycolic acid (PGA) [136, 137]. However, in contrast to
hepatic parenchymal and nonparenchymal co-culture physiology, Kaihara et al. [137] showed
no significant effect on hepatospecific functionality when hepatocytes were cultured with
nonparenchymal and sinusoidal endothelial cell.
Efforts with biomaterials polyurethane (PU) [138], Polyvinylalcohol (PVA) [139], and a
loofa sponge [140]also preserved short –to- medium length culture periods where
hepatospecific functionality was present. Conversely, the best results were obtained with
porous galactosylated chitosan substrate, derived from dried fruit (Luffa cylindrical). Chen
and Lin [141], while using considerably high flow rates (34 ml/min), were able to induce
spontaneous cellular reaggregation to form spheroid masses in excess of 300µm in diameter
and suppress cellular damage caused by hydrodynamic shear stresses. Furthermore and

22
most importantly, albumin and urea synthesis were maintained at levels parallel to that seen
in vivo for the duration of the culture.
2.9

Chitosan as a Biomaterial for Tissue Engineering Constructs
Chitosan (2-amino-2-dexoxy-β-D-glucan), is the fully or partially N-deacytlation

derivatized form of chitin (Figure 1).

By nature chitosan is a linear, hydrophilic, polyamine

copolymer composed of two common in vivo amino sugar constituents; 80% D-glucosamine
and 10% N-acetyl-D-glucosamine [142]. Depending on the source and preparation chitosan’s
molecular weight can range from 50 kDa to 1000 kDa with degrees of deacetylation between
50% and 90%.

Figure 1: Structure of Chitosan Polysaccharide
Eliciting minimal foreign body reaction upon ingestion, implantation or injection,
chitosan is deemed biocompatible.

In addition the polymer possesses a marginal level of

bioburden [143]. In vivo the polymer is bioresorbable and biodegradable via hydrolysis.
Proteolysis, in foremost, is induced by lysozyme [144] however other proteolytic enzymes
have also demonstrated nominal levels of enzymatic activity [145, 146].

Moreover the

degraded artifacts (i.e. amino sugars) are excreted as carbon dioxide or coalesced into the
synthesis of glycoproteins [147]. Considerable factors that are known to affect chitosan’s
degradation kinetics are molecular weight, water content, degree of deacetylation and
molecular architecture.
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At pHs below ~6.5, Chitosan assumes a cationic profile (i.e. linear polyelectrolyte and
high charge (+) density) making it susceptible to electrostatic interactions with a myriad of
negatively charged molecules including soluble proteins, proteoglycans and the extracellular
matrix constituents, glycosaminoglygans (GAGS) [148].

These interactions are also

consistent with anionic cell membranes which have been shown to enhance cellular growth,
attachment, proliferations and cell-tissue reconstruction [149].

Chitosan’s N-acetyl-D-

glucosamine moiety, analogous to that found in GAGS, implies a certain level of bioactivity.
Its presence stimulates macrophagic production of nitric oxide, thus upregulating phagocytic
activity against pathogens and neoplastic cells and jointly affecting several unrelated
biochemical processes such as the cytochrome chain [150, 151]. Moreover, chitosan and
chitin are known to enhance in vitro and in vivo chemoattractivity in neutrophils [152].
Chitosan also possess an intrinsic level of bacteriostatic activity. The interaction
between its reactive amino groups and the negatively charged microbial cell wall suppresses
biosynthesis, thus accelerating death by hindering mass transport across the cell wall [153].
These amino groups as well as its reactive hydroxyl groups can be used in conjunction with
or without each other to facilitate the amiable change of its chemical structure and soluble
properties [154]. Furthermore, chitosan’s physical characteristics in terms of porous structure
and geometrical orientation can be altered through freezing rate, thermal gradient and shape
manipulation [148].
2.10

Computational Fluid Dynamics (CFD) and Bioreactor Cultures
In the last decade computational fluid dynamics (CFD) has found usefulness in

preliminary cells studies and has served as an adjunct to ongoing culture systems.
Computational fluid dynamic modeling holds a comprehensive advantage over trial-and-error
science by incorporating mass, momentum and energy conservation equations to quantify
user defined metrics in steady state/unsteady state, laminar/turbulent flow and
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Newtonian/non-Newtonian flow systems. Furthermore, the understanding of the complex
fluid dynamic environment, prior to the experimental phase, allows for design optimization,
modification, scale-up and determination of system efficacy.
In the early stages of micro-porous construct CFD modeling Raimondi et al. [155]
attempted to characterize and quantify the flow fields and local hydrodynamic stress
distribution imposed on the cellular constituents by experimental flow rates. This effort
explored the use of a simplified 2-D geometry constructed from histological scaffold cross
sections composed of randomly staggered 15µm diameter extruded rod-like fibers. The
results

were inconclusive due to heterogeneous

scaffold architecture,

construct

oversimplification (2-D vs. 3-D) and the adopted boundary conditions used in simulation. The
results were further confounded by the assumption that the shear stress inflicted on the 2-D
structures would be comparable to a non-present cellular population irrespective of cell
packing density. A more recent study conducted by Raimondi et al. [156] employed a scaffold
mimicking, aggregate centered 3-D homogenous open-pore structure to ascertain a more
realistic perfusion induced micro-shear environment. This approached proved to be better
than the aforementioned in terms of predicting and quantifying applied shear stress, however
such parameters that affect shear stress such as spatial position of multiple aggregate
clusters in a finite space were not explored.

CFD has also been used to correlate implied

cellular hydrodynamic stresses at known micro-fluid dynamic conditions to 3-D construct
micro-architecture (i.e. porosity and pore size). For example Boschetti et al. [157] were able
to utilized an homogenous open-pore geometry with varying pore sizes and porosities to
conclude that pore size has a strong influence on the shear stress level experienced by the
cell population. Furthermore, they were also able to establish that porosity distinctly affects
the statistical distribution of shear stresses, not its magnitude.
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Micro-computed tomography (µCT) has been incorporated into CFD work to more
accurately reconstruct the actual micro-structure of tissue engineering scaffolds [158-162].
In particular to simulated fluid flow Porter et al. [163] used this scheme in conjunction with
lattice-Boltzmann method to determine the confined hydrodynamic load imposed on the
internal walls of a reconstructed 3-D porous bone scaffold. Cioffi et al. [164] and Singh et al.
[165] also used an analogous micro-computed tomographic method to recreate porous
constructs to examine local shear stress distribution, flow fields and velocity profiles in a uniaxial and bi-axial rotational bioreactor.
In addition to calculating shear stresses, velocity profiles and flow fields, Williams et
al. [166] was able to model steady state oxygen profiles of O2 saturated media around a nonporous construct in a concentric cylinder bioreactor.

By using a zero-order oxygen

consumption model in conjunction with experimental mammalian oxygen consumption
values, Williams was able to conclude that fluid phase oxygen transport to the nonporous
construct was uniform and that oxygen concentrations within the bioreactor is not a limiting
factor in terms of cell growth.
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CHAPTER THREE: PERFUSION BIOREACTOR OPTIMIZATION, AND
THE TANDEM EFFECTS OF DIRECT AND CONVECTIVE
OXYGENATION ON HEPATIC FUNCTION
3.1 Introduction
Second to skin in size and the brain in complexity, the liver, and its hepatic
constituents, are considered the epicenter for metabolic activity and homeostasis in the
human body.

The highly complex nature and architecture of the liver has burdened

researchers with several challenges that has stifled the fruition of a successful implantable
liver tissue engineered device.

Major hurdles include reestablishing an in-vivo-like

morphological, functional and polarized state that is lost upon disassociation from their nature
ECM micro-environment. However because hepatocytes are highly metabolic and consume
oxygen at a rate 10-fold that of any other cell type [167], the greatest challenge to a viable
tissue engineered construct is an extended oxygen supply that can accommodate a densely
scaffold-seeded hepatocyte mass of 80 to 100 million cells. Insufficient oxygen supply, invitro, can generate a number of intracellular changes that can affects how the liver processes
glucose and vital nutrients [168]. Long-term exposure to O2 limiting/hypoxic conditions would
eventually cause a decrease in protein production and a disruption in cellular metabolism
leading to ATP depletion. This also gives way to the metastable state of mitochondrial
permeabilization transition (MPT), followed by lysosomal disruption, bleb coalescence and
growth, cell swelling, ion dysregulation, enzyme degradation and eventual death either by
apoptosis or necrosis [169, 170].
The goal of liver tissue engineering is to generate a functional 3-dimensional tissue
substitute, in-vitro or de novo, that is morphological and phenotypically relevant with the intent
to restore, replace or improve failing native tissue function [127, 171, 172]. Essential to the
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success of such a device is the synergistic and dynamic interplay of the bioreactor/scaffold
complex. The role of the bioreactor is to aid in the generation of functional liver tissue by
maintaining an environment that is conducive to enhanced hepatocyte maturation, long-term
viability and liver-specific functionality. It accomplishes this by: 1) maintaining a uniform
spatial cell distribution post seeding [173]; 2) providing the necessary biochemical and
biomechanical cues [174, 175]; 3) ensuring that the culture parameters (i.e. pH, O2 tension,
regulatory molecules, temperature and shear stress) are maintained at levels that resemble
the native tissue microenvironment [176, 177]; 4) removal of heptaic by-products and 5)
facilitate efficient external and internal mass transfer of nutrient, regulatory molecules and
oxygen by diffusion and convection [127].
The second half of the complex is the scaffold construct which serves as a
microenvironment that mimics the native tissue and fosters cell maturation. Scaffolds, for
implantation, are composed of biocompatible and biodegradable materials that can provide
the necessary mechanical support, and biochemical and biomechanical stimuli needed for
optimal organ specific functionality [178]. Scaffold that have open, interconnected pore
networks are essential to neo-tissue formation as they aid in cell nutrition, proliferation and/or
migration, angiogenesis and serve as anchor points with the surrounding natural tissue
structure post implantation [179-182].
Within the last decade researchers have sought to tackle O2 transport limitations, in
3D hepatic cultures, by increasing the amount of available oxygen with synthetic or natural
oxygen carriers and bioreactor culture systems.

Shi and Coger [183] utilized

perfluorocarbons (PFC) with Gelfoam gelatin sponge scaffolds in perfusion. They saw a 7.6
fold net increase in EROD activity (resorufin production rate) in cells culture with PFC vs.
standard conditioned media. C3A cells cultured with PFCs in perfusion had 9 fold increase
in the number of metabolically active cells. Another study conducted by Palmer and Chen
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utilized bovine hemoglobin (BvHb) infused media in a hollow fiber bioreactor culture. Their
results showed that hepatocytes within this experimental setup exhibited improved hepatic
metabolism and drug clearance, and preserved higher hepatocyte specific functionality in
comparison to controls with no BvHb [184].
In this study we sought to fabricate a viable 3-demesional chitosan scaffold embedded
with gas permeable silicone tubing to accommodate high density cell seeding and simulate
capillary-like direct oxygenation to adjacent hepatocyte cellular masses. We also designed
and optimized a perfusion bioreactor system that seamlessly integrates with the
aforementioned chitosan scaffold for long-term culturing. The main goal of this study is to
evaluate the synergistic effect that the aforementioned bioreactor/scaffold complex has on
the morphology, viability and phenotypic expression of densely seeded hepatocytes in
culture.

The working hypothesis is that an optimized bioreactor and optimized culture

conditions, plus the concomitant effect of direct oxygenation and convective mass would lead
to improved hepatocyte metabolic output.
3.2

Materials and Methods

3.2.1 Sources of Materials and Reagents
Medium molecular weight chitosan and glacial acetic acid were purchased from Sigma
Aldrich (St. Louis, MO).
3.2.2 Scaffold Fabrication
For these studies, highly purified, medium molecular weight chitosan was employed
(90% deacetylated, M=350 kDa) for three dimensional scaffold formation. The geometry of
the porous construct is cylindrical in shape with dimensions of 2.5 cm height by 1.5 cm width.
The scaffold fabrication process was adopted from the freezing and lyophilization principles
and techniques employed by Matthew and Madihally [148]. The construct was formed in a
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cylindrical metal mold fitted with a teflon rod to create a central port to facilitate uniform
seeding and medium/nutrient perfusion. To perpetuate direct oxygenation of the cellular
content, eight axially-orientated, gas permeable silicone tubes were incorporated into the
chitosan construct.

The three dimensional porous structure was formed by freezing a

chitosan/collagen solution (1.5 wt%/.15% vol in .2M acetic acid).

The freezing will be

accomplished by immersing the chitosan/collagen-filled mold in liquid nitrogen for 10 seconds
followed by immersion in a dry ice-chilled methanol bath for 24 hours. Subsequent to
freezing, lyophilization was employed to remove pore trapped ice crystals.

Scaffold

rehydration and acetic acid neutralization was attained by immersion in 100% ethanol and
sterilization by immersion in 70% ethanol followed by several washings in a phosphate buffer
saline solution (PBS) and culture medium prior to cell seeding (Figures 2 and 3).
The pore direction and size were created and regulated by thermal gradient orientation
and magnitude, respectively. Implemented during the freezing process, the gradient was
created by using a scaffold-centered teflon tube containing 80°C isopropanol.

This

application creates a tapered radial-orientated pore structure with the larger pores (100 to
400 µm) at the central port and the smaller pores (10 to 50 µm) at the scaffold periphery.
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Figure 2: Schematic and 3D Rendering of Chitosan Scaffold with Silicone Tubing

Figure 3: Top, front and angled view of chitosan scaffold embedded with gas permeable
silicone tubing
3.2.3 Hepatocyte Isolation
Hepatocytes were isolated from Fisher rats by a modified two-step collagenase
perfusion technique. Post anesthetization by intramuscular ketamine and xylazine injection,
the abdomen was open via midline incision. Subsequent to cannulation of the portal vein,
the liver was flushed with 250 ml of Krebs-Ringer bicarbonate buffer (KRB) containing .4
mg/ml EDTA at a low constant flow rate. Upon complete evacuation of blood from the liver,
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the perfusate was changed to 250 ml of KRBB containing .5 mg/ml collagenase (Type IV)
and .3 mg/ml CaCl2 .2H2O. Perfusion continued until the liver became flaccid and blanched
in appearance, indicative of ECM breakdown and loss of anatomical structure. It should be
noted that both solutions were maintained at 37•C water and circulated through sterile tubing
via peristaltic pump. Upon completion of the enzymatic treatment, the liver was expunged
and transferred to a beaker containing 50 ml of HBSS containing 2% bovine serum albumin.
Cell liberation was achieved by blunt mechanical dissection of the Gissle capsule and mild
organ agitation.

The cell suspension was centrifuged at 500 rpm for 5 minutes and

supernatant was removed by aspiration.

Following two additional HBSS/albumin washes,

cells were resuspended and aliquoted for assessment of cell density/concentration and
viability. Said measurements were conducted under microscopic view using hemacytometer
and trypan blue exclusion.
3.2.4 Culture Conditions
The medium used in all hepatocyte cultures was high glucose (4.5 g/L) Dulbecco’s
Modified Eagle’s Medium (DMEM) with 4.5supplemented with the following additives: 10%
Fetal Bovine Serum (FBS), 20 ng/ml Epidermal Growth Factor (EGF), 0.5 U/ml Insulin, 7
ng/ml Glucagon, 7.5 ng/ml Hydrocortisone, 200 U/ml Penicillin, 200 µg/ml Streptomycin and
20 µg/ml L-proline.
Subsequent to dynamic seeding and cell entrapment, hepatocyte cultures were
maintained in a constant atmosphere of 95% O2 air/5% CO2. Cultures perfused with a more
acidic medium (~ pH 7.2), were preserved in an atmosphere of 90% O2/10% CO2. The
respective atmospheric gas mixture applied to each culture was also supplied through
oxygenation tubing. The flows rate applied in perfusion was approximated based on the cell
number and literature values of hepatocyte oxygen consumption using the following equation:
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Q (ml/min) =

OUR
N(t)
So 2 [P in − P out ]

Where:
OUR =

oxygen uptake rates of freshly isolated HCs (0.4 nmol/s/106 cells)

Q

=

medium flow rate, ml/min

So2

=

Solubility of oxygen in saline at 37°C (1.29 nmol /ml/mmHg)

Pin

=

Inlet partial pressure (155 mm Hg)

Pout

=

Outlet partial pressure (5 mm Hg)

N

=

Number of viable cells in culture (million)

T

=

Time conversion factor (60sec/min)

It should be noted that the final value was doubled to mitigate mass transfer limitations.
Albumin protein synthesis and ureagenesis assays were performed to assess efficacy
of bioreactor studies. The perfusion cultures contained a cell quantity of no less than 50
million. As a rule of thumb, the ratio of 1ml of culture medium per million viable entrapped
hepatocytes per day was employed to determine the volume of medium circulating within the
perfusion circuit. An additional 10 milliliters of extra medium was added to curtail any nutrient
restrictions.
For the metabolic and protein synthesis comparison studies two double layer collagen
sandwich culture systems were run in parallel with each bioreactor and utilized as controls.
For these control cultures single cell hepatocytes were plated at a density of 1 million cells
per 9.5cm2 culture dish.

Culture medium volume of 1ml per dish was used.

Plated

hepatocytes for the first 24 hours of culture were maintained on a single layer of collagen.
On day two the unattached or non-viable cells were removed and the second layer of collagen
was integrated into the system. The medium of 1ml per dish was maintained throughout the
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cell culture. However for metabolic output assays, from day two onward, the final synthesis
rates were doubled to account for the second ml of medium in the top collagen gel layer.
The medium was extracted and replenished daily for both culture systems.

All

samples were store at 4°C until analysis were perfo rmed. Hepatocyte morphology and
viability were ascertained by Hematoxylin and Eosin Y staining.
3.2.5 Metabolic Output Measurements
Enzyme Linked Immunoassay (ELISA) for Albumin
The rate of albumin secretion was quantified by an ELISA using an antibody specific
to rat albumin. The assay is based on the principle of antibody capture with antigen
competition. Immunoassay plates (96 well) were coated with 100 µl of coating buffer
containing chromatographically purified rat albumin (Cappel), and incubated overnight at 48°C. The plates were washed four times with PBS/Twe en solution, then 50 µl of samples or
standards and 50 µl of peroxidase-conjugated sheep anti-rat albumin antibody in PBSTween, the working solution was 1:10) (Bethyl Laboratories) was added and plates incubated
again overnight at 4-8°C. The plates were washed ag ain and 100 µl of substrate mixture
consisting of 25ml of substrate buffer and one capsule 10 mg of o-phenylenediamine
dihydrochloride (OPD) (Sigma) and 10 µl of 30% hydrogen peroxide. The mixture was added
to a row of wells every 10 seconds the reaction stopped after 5 min with 50 µl of 8 N sulfuric
acid. Plates read immediately at 490nm and the optical density obtained using SOFT max
Pro device (Molecular Devices Spectramax 250). The concentration of albumin is inversely
proportional to the optical density measured. The standards were plotted on a semi-log
standard curve. The unknowns are interpolated from the logarithmic fit of the standard curve.
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Urea Assay
Urea secretion was measured using the diacetyl monoxime method which is a
colorimetric analysis that directly determines the concentration of dissolved urea [85].
Collected samples were mixed well and 350 µl of each sample was transferred to
microcentrifuge tubes, 25 µl of reagent A consisting of Diacetyl Monoxime 8.5g in 250 ml
dH O (J.T.Baker) and 10ml Thiosemicarbazide solution,0.95g in 100ml dH O (TCI.Mark) is
2

2

added and the solution was mixed, then 80 µl of reagent B consisting of 300ml concentrated
sulfuric acid diluted to 535ml with dH O together with 0.5ml ferric Chloride solution,0.15g in
2

10ml dH O was added and the solution mixed well and placed in a water bath at 85°C for 20
2

minutes. Urea nitrogen solution (150 mg/dl, Sigma) was used as a standard and treated the
same way as the samples. Following the incubation, samples were cooled in tap water for 5
min, the water was changed and the samples cooled for another 5 min. 150 µl of standard
and samples were transferred into a 96 well plate and the absorbance of the solution was
read at 520 nm using a microplate spectrophotometer system. The concentration of urea was
proportional to the obtained optical density (OD).
3.2.6 Histological Analysis
For histological examinations, scaffold samples, after each 7 day culture, were fixed
in 4% paraformaldehyde for 2 days. The fixed samples were, processed, and embedded in
paraffin, followed by microtome sectioning to obtain 5 µm thin horizontal slices. The sections
were mounted on slides, deparaffinized, rehydrated and stained with Hematoxylin and Eosin
(HE). Images were taken with a transmitted light microscope.
3.2.7 Statistical Analysis
The biochemical functional output of the hepatocytes for bioreactor design iterations
1 and 2 in sections 3.3.2(a) and 3.3.2(b) respectively, were calculated from single cultures.
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The results from the third generation bioreactor cultures in section 3.3.2(c) were calculated
form duplicate runs. The rates per day, where applicable, were averaged across duplicate
runs and values are reported as mean ± standard deviation.
3.3

Results

3.3.1 Scaffold Characterization
Scanning Electron Microscopy was utilized to characterize the pore size at the
scaffold’s central port and periphery. This technique was also used to assess the orientation
and sloped gradient of the interconnect pore structure from the central port to the periphery.
Post fabrication, scaffold were vertically and radially cut, and gold sputter coated before
characterization. We observed pore sizes ranging from 100-400 microns in the central
port/fluid inlet and 10-35 microns at periphery/fluid outlet (Figure 4). The internal pore
structure exhibited a high level of interconnectivity with a radial, tapered orientation
decreasing from the central port to the periphery by a magnitude of 10.
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Figure 4: Scanning Electron Micrograph images of 3-dimensional chitosan scaffold. Vertical
cut shows the pore size in the central port/fluid inlet (a) and scaffold periphery/fluid outlet (b).
Radial cuts show tapered orientation and magnitude of interconnect pore structure at the inlet
(c) and outlet (d).
3.3.2 Bioreactor design/optimization and the effects of 3D chitosan scaffold with
direct and convective oxygenation on hepatocyte phenotypic expression
The reactor system was designed and developed with four goals in mind: First,
accommodate high density seeding and even cell distribution; Second, provide sustained
direct oxygenation to hepatocyte entrapped scaffolds, through integrated gas-permeable
silicone tubing; Third, ensure adequate mass transfer via radial perfusion and, convective
and diffusive flow; Fourth, maintain in vitro liver-specific functionality for the duration of the
experimental run.
Scaffolds were seeded with 50, 80 and 85 million hepatocytes at a density of one
million cells/ml and a flow rate of 20 ml/min. Seeding was conducted using oxygenated
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medium, direct scaffold oxygenation via semi-permeable tubing. The bioreactor system,
during seeding, was seated on a flat cold pack to minimize temperature fluctuations. The
cold environment aided in maintaining hepatocyte viability and mitigated metabolic behavior
until cells were adequately housed in the chitosan scaffold. Seeding duration continued until
desired seeding density was achieved. This information was ascertained by retrieving and
counting the remaining cells in suspension every 10 minutes. Once the desired density was
achieved the remaining cell suspension was removed and the perfusion system was
replenished with fresh culture medium. Subsequent to seeding and medium replenishment
the reactor system was relocated to a climate controlled incubator and cultured at 37˙C for
the duration of the experiment. Experiments conducted with the first and second bioreactor
designs were cultured under 95% air/5% CO2 balance. The experiments with third iteration
bioreactor design were conducted under 90% air/10% CO2 balance.
3.3.2(a) First Generation Bioreactor Design and Results
The first generation bioreactor system (Figure 5) was fashioned from a 45 ml glass jar
which served as the cell seeding and perfusion/culture chamber.

The medium

reservoir/bubble trap was fabricated from a 10 ml polysulfone tube. The reservoir was fitted
with a .22 µm filter which served as a sterile air vent. Before entering the culture chamber
the conditioned medium first passed through 3 meters of coiled gas permeable silicone tubing
(2 mm ID) that was placed in a sealed bag purged with a 95% air/5% CO2 mixture. The
sealed enclosure regulated the pH and functioned as an oxygenator for the culture medium.
Upon exiting the perfusion chamber medium was pumped to the reservoir/bubble trap then
the oxygenator and then back to the culture chamber.

This particular perfusion circuit

ensured the consistency of the gas mixture and pH were maintained before entering the
culture chamber and cell seeded scaffold. The flow rate needed for cell survival was
estimated based on cell mass and reported values of nutrient consumption. Circulation was
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achieved by means of a peristaltic pump placed between the reservoir and oxygenator.
Stopcocks were used for sampling during seeding for cell counts and viability measurements.
They were also used for acquiring sample aliquots during the culture and medium exchange.
The entire perfusion unit was sterilized and maintained in a 37°C incubator for the duration
of the culture. The system was replenished with fresh medium every 24 hours and sample
aliquots were stored at 4 °C for later metabolic an alysis. In this trial the scaffold was seeded
with 50 million hepatocytes and cultured for 21 days. The duration of the seeding process
was 35 minutes.

Figure 5: Schematic of first generation perfusion culture circuit with expanded, detailed
schematic of the bioreactor chamber. The bioreactor image shows the fluid path from inlet to
outlet, oxygenation tubing and, orientation and position of the scaffold with seeded
hepatocytes.
Figure 6 shows a plot that compares albumin secretion for the perfusion and control
cultures over time. For the duration of the experiment, the perfused hepatocytes were able
to secrete albumin. However it is clearly evident that the levels of activity, when compared to
the control culture, are significantly depressed.

Although albumin synthesis declined
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continuously, measurable amounts were still noticeable at day 21. The highest level of
synthesis, 3.72 µg/million cells/day, was seen on day 5.
Figure 7 shows similar trends in ureagenesis. However, urea production was seen to
slightly increase by day 4, but declined immediately thereafter and maintained low levels for
the duration of the culture. The highest level of production was seen on day 4 with a value
of 10.08 µg/million cells/day.
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Figure 6: Rate of albumin synthesis produced by hepatoctyes cultured in first generation
bioreactor system at a flow rate of 10 ml/min vs. double layer collagen gel control. Secretions
rates for control were significantly higher when compared to perfusion bioreactor model.
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Figure 7: Rate of Ureagenesis produced by hepatocytes cultured in first generation bioreactor
system at a flow rate of 10 ml/min vs. double layer collagen gel control. Secretion rates for
control significantly outpaced those exhibited by the perfusion culture.
Mild hepatocyte aggregation was noticed at the conclusion of the culture. The extent
of aggregation was confined to near the central port (Figure 8 A and B) and the oxygenated
tubing (Figures 8 C and D). Aggregates in these regions assumed a liver-like morphology
with noticeable variation in size and geometry. Aggregates located in close proximity to the
central port were more numerous, contained an elevated aggregate mass and were more
spherical in shape, in comparison to those near the oxygen tubing. In terms of viability, single
cell hepatocytes exhibited no viability, while aggregated cells displayed signs of minimum
viability at best. Viable cells within aggregates from both regions were observed, to a greater
degree, on the periphery than the midsection. It was concluded that cells in this region of the
aggregate died from necrosis due to oxygen and nutrient deprivation.
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Figure 8: H&E staining of hepatocyte seeded in the high oxygenated regions of the scaffold
post 21 days of culture in first generation bioreactor system. A & B) Cell aggregates at the
central port, C & D) Cell aggregates adjacent to integrated oxygenation tubing. A & C were
taken with a 5x objective magnification lens. B & D were taken with a 10x objective
magnification lens.
Many difficulties, with the current bioreactor design, were encountered during multiple
culture runs. These issues included, but were not limited to, scaffold reorientation during the
cell seeding or culturing process. Adhesive seal breakage at reactor/luer and reservoir/luer
connection points which lead to medium leakage and subsequent contamination. Lastly on
multiple occasions uneven pressure throughout the perfusion circuit lead to medium overflow
in the reactor chamber and the emptying of the reservoir which introduced bubbles into the
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system. Because of these issues a second full experiment could not be reproduced and a
second generation bioreactor design was implemented.
3.3.2(b) Second Generation Bioreactor Design and Results
The need for a second generation perfusion reactor system stemmed from multiple
design flaws with its predecessor that hindered reproducible long-term cultures. Such flaws
included scaffold reorientation during seeding and culture, and inefficient cell seeding due to
cells being ejected from the top of the central port instead of being seeded into the scaffold.
The reactor also experienced material and adhesive failure on several occasions at reactor
cap and luer lock connection points respectively. This lead to pressure differentials and
uneven fluid flow across both chambers.

This flaw was due to sterilization process

(autoclave) which ultimately lead to device failure during culture. To address these issues
the second generation system was completely fabricated from heat tempered glass with the
lure/tubing connections integrated into the cap (Figure 9). The scaffold reorientation issue
was resolved by adding a basket to the perfusion chamber which immobilized the scaffold
during the seeding and culture periods. A cap, used to seal the scaffold-perfusion tubing
interface, mitigated cell pluming during the seeding process and back pressure fluid flow
which previously allowed media to flow out of the central port versus through the scaffold.
Lastly the reactor cap and chamber were fabricated to accommodate o-ring which created a
secure seal between the parts and helped to maintain even pressure across the flow circuit.
The geometry and flow circuit of the new system resembled that of its predecessor however
the fluid capacity of the perfusion chamber was greater at 60 ml versus 45 ml.
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Figure 9: Schematic of second generation perfusion culture circuit with expanded, detailed
schematic of the bioreactor chamber. The bioreactor image shows the fluid path from inlet to
outlet, oxygenation tubing and, orientation and position of the scaffold with seeded
hepatocytes.
This experiment sought to evaluate the efficacy of the second generation perfusion
bioreactor system with our chitosan scaffold embedded with semipermeable silicone tubing
for diffusion based oxygenation. Just as important was to asses if this complex better
supports hepatocyte-specific functionality, morphology and viability throughout the culture
period.

In this trial the scaffold was seeded with 80 million hepatocytes and cultured for 7

days. The seeding for this trial slightly deviated from the previous in that direct oxygenation,
via the integration silicone tubing, was implemented during the process. The seeding process
did not exceed 15 minutes.
The results in Figure 10 showed that hepatocytes in the perfusion culture were able
to sustain secretion over the duration of the 7 day culture period. The initial synthesis rate
of the perfusion culture surpassed that of the control and reached its peak on the second day
with a maximum output of 11.67 µg/million cells/day. However, over the next four days,
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production rates displayed a consistent decline as compared to the control which saw value
increase throughout the culture. The lowest rates for the bioreactor culture were seen on day
6 with values of 1.99 µg/million cells/day.
The results from the urea secretion assay (Figure 11) showed that hepatocytes
cultured in the perfusion system had drastically lower function when compared to the control.
Ureageneis, like albumin synthesis, exhibited higher synthesis rates at the onset of the culture
when compared to the control (9.16 vs. 4.92 µg/million cells/day). However as the culture
progressed urea secretion continued to decline with the lowest value of 1.62 µg/million
cells/day on day 6.

Albumin Protein Synthesis (pH 7.4)
70
60

Perfusion Bioreactor 10ml/min
Double Layer Collagen Gel (Control)

ug/million cells/day

50
40
30
20
10
0

0

1

2

3

4

5

6

7

8

Days In Culture

Figure 10: Rate of albumin synthesis produced by hepatoctyes cultured in the second
generation bioreactor system at a flow rate of 10 ml/min vs. double layer collagen gel control.
Secretions rates for control were significantly higher when compared to perfusion bioreactor
model.
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Figure 11: Rate of Ureagenesis produced by hepatocytes cultured in the second generation
bioreactor system at a flow rate of 10 ml/min vs. double layer collagen gel control. Secretion
rates for control significantly outpaced those exhibited by the perfusion culture.
At the end of the experiment histology showed mild to strong aggregation throughout
the scaffold.

Again, aggregates varied drastically in size and geometry with higher

concentrations near the high oxygenated regions (i.e. Central port and the oxygenated tubing)
(Figures 12 A and B, C and D). Viable cells in these areas were once more only noticed
when only encapsulated in a collective mass. The position of active cells within the various
aggregated showed no finite pattern given that functioning cells were observed at the
boundary as well as in the aggregate interior. In contrast to the previous culture, aggregation
was also observed in areas around the scaffold periphery. However, aggregates viewed at
the construct perimeter revealed a smaller collective mass with little to no viability.
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Figure 12: H&E staining of hepatocyte seeded in the high oxygenated regions of the scaffold
post 7 days of culture in second generation bioreactor system. A & B) Cell aggregates at the
central port. C & D) Cell aggregates adjacent to integrated oxygenation tubing. A & C were
taken with a 5x objective magnification lens and B & D were taken with a 10x objective
magnification lens.
Although the design modifications did improve hepatocyte phenotypic expression as
exhibited by the increased metabolic and protein outputs.

This system, like the first

generation bioreactor, did experience multiple functional issues which hindered it
performance during the seeding and culturing processes. Such problems included inefficient
fluid recirculation through the perfusion circuit. This functional flaw lead to cells settling out
of suspension on the chamber floor during the seeding and subsequent culture period. Being
that the geometry and configuration of this system was analogous to its predecessor, these
finds would suggest this was an issue with the first generation system too. Lastly the unsturdy
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nature of the glass material made it quite challenging to handle and manipulate during both
processes. This gave way to contamination during media exchange, compromised scaffold
integrity during reactor system integration and, breakage while transporting and in storage.
Due to these issues the reproduction of meaningful data was impossible and prompted a
complete system redesign.
3.3.2(c) Third Generation Bioreactor Design and Results
The bioreactor/seeding chamber system in this iteration consisted of a 20cc chamber
that served as the culture chamber and a 60cc chamber which served as a medium reservoir
and bubble trap (Figures 13 and 14).

In this iteration scaffold/reactor integration was

accomplished quite easily by one person. In addition to being an entrance and egress for the
direct oxygenation, the cannulas also served as anchor points for scaffold stabilization when
attached to the embedded silicone tubing. Once attached and fully integrated into the system
the scaffold was seated on and supported by a wire mesh. The cells, during the seeding
process, and the path of media during the culture flowed in from the top of the culture
chamber, into the scaffold and egressed through the bottom of the chamber. A stopcock was
placed between the culture chamber outlet and media reservoir for samples acquisition and
medium changeover. The flow circuit for this bioreactor resembled that of the previous two
iterations. The complete system was autoclaved and assembled under sterile conditions
before being used in seeding and culture applications.
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Figure 13: Schematic of complete third iteration perfusion culture circuit with expanded,
detailed schematic of the bioreactor chamber. The bioreactor image shows the fluid path
from inlet to outlet, oxygenation tubing and orientation of trapped hepatocytes.
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Figure 14: Bioreactor culture setup showing cell seeded scaffold, medium reservoir and
oxygenator
This experiment sought to evaluate the effect that direct oxygenation and convective
transport, with the third generation bioreactor system, have on hepatic biochemical output,
viability and morphology.

In addition to the redesigned bioreactor chamber we also

decreased pH of the culture media to ~7.2 by doubling the percent concentration of CO2. The
rationale behind this was to have the pH of the medium mimic portal venous conditions,
thereby exposing the hepatocytes to a more in vivo-like milieu. In this trial the scaffolds were
seeded with an average of 85 million hepatocytes and cultured for 7 days. The seeding
process did not exceed 15 minutes.
The rates for protein synthesis for experiment are exhibited in Figure 15. In general
the albumin rates for the plated control exceeded those of the perfusion reactor system.
However rates, for the duration of bioreactor culture, did not fall below 4.17 ug/million
cells/day. This was not seen in previous experiments. Additionally this perfusion culture kept
pace with the static control until day three with average levels peaking on day four (9.58
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ug/million cells/day). Thereafter the rates of production were considerably distant. It should
also be noted that for the duration of the culture, day-to-day production levels exhibited only
minor fluctuations versus a continuous downward trend seen in the previous cultures.
Mean urea synthesis for each day of culture can be seen in Figure 16. Although
ureagenesis was measureable for each day, it seemed to follow the common trend of
elevated production at the onset followed by a stable decline in output. The highest level of
production, 11.797 and 10.17 µg/million cells/day, were seen on day 1 and 2 which did
surpass the control values of 10.6 and 8.5 µg/million cells/day for both days respectively.
Nonetheless, outputs during this run were consistently higher than those seen in the previous
trial.
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Figure 15: Rate of albumin synthesis produced by hepatoctyes cultured in third generation
bioreactor system at a flow rate of 10 ml/min vs. double layer collagen gel control. Secretions
rates for control were significantly higher when compared to perfusion bioreactor model.
Error bars represent standard deviation of 2 replicate measurements.
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Figure 16: Rate of Ureagenesis produced by hepatocytes cultured in third generation
bioreactor system at a flow rate of 10 ml/min vs. double layer collagen gel control. Secretion
rates for control significantly outpaced those exhibited by the perfusion culture. Error bars
represent standard deviation of 2 replicate measurements.
Upon experimental cessation, histological examination showed the cellular
constituents were less likely to retain their single celled appearance, thus favoring intense
aggregation in multiple scaffold regions. Heavy aggregation was yet more prominent in and
around the high oxygenated areas (Figure 17 A to D). In contrast to prior trials, more
aggregation was detected at the construct’s outer radius. It was also observed that the
cellular masses resembled an ellipsoid-like geometry as appose to an irregular configuration.
Viable cells were found randomly dispersed within most aggregates located in the so called
high oxygenated areas, however the level of functionality was not elucidated.
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Figure 17: H&E staining of hepatocyte seeded in the high oxygenated regions of the scaffold
post 7 days of culture in third generation bioreactor system. A & B) Cell aggregates at the
central port, C & D) Cell aggregates adjacent to integrated oxygenation tubing. A & C were
taken with a 5x objective magnification lens and B & D were taken with a 10x objective
magnification lens.
In addition to measuring against a control, results from all three designs were plotted
together and compared versus each day in culture. In order to accurately compare and draws
conclusions across the three designs, results on days 8 to 21 from the first generation
bioreactor were omitted from the figures. Figure 18 shows the compared results for albumin
synthesis versus each day in culture for the three bioreactor systems. When compared it is
quite evident that production levels from the first generation system pales in comparison to
generation 2 and 3. Only do rates on day 5 for the first generation system exceed those from
the other bioreactors. Similar trends in activity, for the most part, can be seen in the second
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and third generation systems. Other than day 7 for both systems and day 4 for the third
generation reactor – production levels increase on 1 and 2, and decrease thereafter.
A paired t-test was performed on all samples from each system; there was no
statistically significant differences in albumin synthesis rates between hepatocytes cultured
in the second and third generation systems. However there was a significant differences in
generation 1 vs. 2 and generation 1 vs. 3 (p > .05).
Urea synthesis rates comparing each bioreactor over 7 days of culture are shown in
Figure 19.

Similar to the compared albumin rates, the third generation system, for

ureagenesis, outperformed the other two systems. As expected when compared, trends for
the second a third generation system are similar in that increased rates at the onset followed
by declining expression as the culture progressed. The first generation reactor also followed
a similar trajectory until day 4 where a spike in production is seen followed by a precipitous
drop in activity. The reason for this increased synthesis is unclear.
A paired t-test was performed on all samples from each system; there was no
statistically significant differences in albumin synthesis rates between hepatocytes cultured
in the first versus second, and first versus third generation systems. However there was a
significant differences in generation 2 vs. 3 reactors (p > .05).
Based on the results from the three different bioreactors, the third generation
configuration was chosen as the system to be used to evaluate the effects that shear stress,
generated by varying flow rates, has on hepatocyte viability, functionality and morphology.
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Figure 18: Albumin protein synthesis rates for hepatocytes cultured in first, second and third
generation perfusion bioreactors.
Days 8 to 21 were excluded from the first generation
reactor culture to better compare the outputs rates between the different reactors.
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Figure 19: Ureagenesis rates for hepatocytes cultured in first, second and third generation
perfusion bioreactors. Days 8 to 21 were excluded from the first generation reactor culture
to better compare the outputs rates between the different reactors.
3.4

Discussion
The ultimate goal of hepatic or liver tissue engineering is to make an implantable, liver

equivalent that is comparable to the native organ in size, cell density and functionality. Being
that hepatocytes are highly aerobic, the science has been stymied due to the lack of a viable
substrate that can bio-mimetically recapitulate the oxygen tension of the hepatic
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microenvironment. Studies have attempted to satisfy this demand by using decelluarized
livers as pre-vascularized scaffolds, designing bioreactors that minimize mass transfer
limitation, hepatocyte encapsulation with VEC cells and oxygen carriers – to name a few.
However results, although promising have not produce a viable solution.
The bi-phasic approach in this study was to; 1) investigate the synergistic
effects of bulk convective mass transport (perfused oxygenated media) and capillary-like
direct oxygenation on hepatocyte functionality and 2) design a perfusion bioreactor system
that could accommodate both modes of oxygen delivery.
The level and trend of protein synthesis increased with each bioreactor design
iteration.

The greatest difference was noticeable between the first and second design

iterations. There were several possible reasons for this. All of which are debatable, however
it’s believed that the two main contributors are; 1) the cap that created a seal at the scaffold
inlet. This aided in directing flow through the structure thus minimizing reverse flow possibly
caused by back pressure from the scaffold’s tapered porous structure and cellular inhabitants.
This facilitated better mass transfer of oxygenated media and nutrients, and removal of waste
by-products. Lastly, this drastically reduced the seeding time and subsequent cell-to-ECM
integration period which enabled the hepatocytes to reestablish their lost polarized state more
quickly. 2) Implementing direct oxygenation during the seeding process. It has been shown
that hepatocytes consume three-fold more oxygen during or shortly after the inoculation
process [185]. Because of this it is not unreasonable to deduce that the superior functional
capacity, was partially due to the support that the additional oxygen provided during the
seeding process.
Similarly, there were two major modifications made to the third generation system that
brought about a significant improvement in phenotypic expression and viability when
compared to the previous generation. The pH of the culture media was acidified and reduced
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to 7.2 which brought it more in-line with the average hepatic intracellular pHi of 7.16 [186].
Studies conducted by Halladay et. al [187] determined that the intracellular pHi of
hepatocytes, in culture, equilibrates to that of its culture media, which in this case is 7.4. This
could explain the difference in functionality because a more acidic intracellular pH has been
shown to protect hepatocytes against the onset of cell death especially during time of ATP
depletion [188].

Secondly the size and volume capacity of the culture chamber were

drastically reduced and the chamber floor was slightly tapered at the outlet. The flat bottom
and wide diameter design of the second generation reactor allowed thousands of cells to fall
out of suspension and settle on the chamber floor either during seeding or culturing. The
design proved to have inadequate media recirculation characteristics which could have led to
zones of stagnant or “no” flow and pH imbalances in these areas. It was also suspected that
waste by-products from viable cells or toxic substances released from dead cells that settled
out and adversely affected the culture. This could have also contributed to the reduced
performance from the first bioreactor system.
It was noticed that the urea and protein production from second and third generation
bioreactor cultures surpassed that of the control on the first and/or second day. When taken
into physiological context this makes perfect sense. Vinken et al. [189] and Hewitt et al. [190]
both showed that hepatocytes, once disassociated from the liver capsule, become
depolarized and when cultured on monolayers experience a progressive loss of liver-specific
function and morphological abnormalities. It was not until the second collagen layer was
added, which created a 3D substrate, that a markedly increase in function which observed in
the control cultures. This trend was not seen in the first generation system. It is likely due to
the cells being ejected from the top of central port instead being seeded into the scaffold
during the seeding process. This contributed to the extended time period for cells outside of
an ECM-like milieu (scaffold) and subsequent depressed cellular activity. It is also believed
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that the extended seeding period, a consequence of the pluming effect, prolonged the
exposure of the already entrapped cells to harmful hydrodynamic forces which are known to
compromise hepatocyte functionality [191-193]. The harmful effects that prolonged exposure
to excessive shear stress have on hepatocyte viability will be discussed in detail in a later
chapter.
Advanced hepatocyte aggregation and the frequency of aggregation are two factors
believed to have played a significant role in enhanced performance of reactors 2 & 3 over 1.
In both systems increased levels of aggregation was observed in high oxygenated areas (inlet
and adjacent to oxygen tubing). Viable hepatocytes, when clustered, can form gap junctions
which are essential to hepatocyte function and survival as they provide pathways for
communication between adjacent cells and regulate a number of liver-specific functions [194,
195]. Although not characterized in this study the lack of aggregation and gap junctions could
be one reason, amongst several, as to why depressed functional activity was observed in
reactor version 1. Additionally the cells on the periphery of these aggregates are most likely
in contact with the scaffold and form integrin mediated adhesion anchor points – which too
are need for cell survival through, but not limited to, the beta1-ILK-pAkt pathway [196, 197].
In addition to minimal O2 limitations, this would point to why more viable cells were localized
around the aggregate periphery.

It should be also noted that the same aggregation

contributed to the subpar functional performance of these same two system. From the H&E
stains the 2-dimension measurements of numerous aggregates are several hepatocytes in
width and length. The unknown, but critical, characteristic that also complicates this even
further is the height of each aggregate.

Hepatocytes that are more than 1 to 3 mm away

from an oxygen or nutrient source will succumb to mass transfer limitations [198]. This is
evident as more hepatocytes in the interior of the aggregates are non-viable. Those that do
survive will function at depressed levels. What exacerbates the issue is not being able to
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remove non-viable cellular matter as this is known to release noxious degraded substances
which could injure an otherwise healthy cells or accelerate the cell death machinery of a
fragile adjacent cell.
Several reactor modifications contributed to the final bioreactor design.

Such

modifications, as stated in the previous section, enhanced the overall performance and
sustainability of the hepatocytes in culture. The results from the third generation study were
compared to data (not published) reported by a previous colleague who used a similar
scaffold structure but different bioreactor design. Albumin production in both studies were
maintained for the duration culture. In the study conducted by my colleague an average peak
synthesis rate of 2.88 ug/million cells/day was reported on day 1 followed by a sharp decline.
The average peak production rated for this study, as seen on day 5, exhibited a 22.5% (3.72
ug/million cells/day) increase over the aforementioned rate. The compared results clearly
show that the bioreactor design in this study better supports hepatocyte-specific functionality
and viability.
Metabolic Rates: Comparison with Oxygen Carrier Augmented Cultures
To date the lion’s share of research dealing with oxygen supplementation for
enhancing hepatocyte viability and metabolic performance has not focused on usage with 3D
scaffolds for implantation modalities.

Instead research efforts have utilized oxygen

supplementation, in the way of perfluorocarbons (PFC) and hemoglobin-based O2 carriers
(HBOC), for extracorporeal liver devices or toxicity screening. It has been well documented
that functional and morphological characteristics of hepatocytes, primary or cell lines, differ
based on their in-vitro milieu, substrate/ECM or end-point therapeutics.

Because of this it

would be difficult to provide conclusive comparisons with the results from this study and the
research done with O2 medium supplements. However trends in metabolic activity and
viability, in perfusion bioreactor cultures only, will be compared.
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The only study, to date, that has evaluated a 3D scaffold construct for implantation
purposes, in perfusion supplemented with PFC for enhanced oxygenation, exhibited
significantly lower rates of albumin synthesis when converted and compared to this study’s
3rd generation bioreactor setup. Shi and Coger [183] cultured HepG2/C3A hepatocytes in
Gelfoam ® gelatin sponge (Pharmacia & Upjohn) for 48 hours and saw an average rate of
600 ng/million cells/day vs. 9.070 ug/million cells/day in this study.

Although a true

comparison cannot be made between the rat hepatocytes in this study and human
HepG2/C3A cells it was surprising to see there was no significant difference between the
PFC supplemented culture and control. This would suggest that PFC, in this instance, had
no functional effect. In contrast to Kinasiewicz et al. [199] who saw increasing albumin
synthesis from the onset of his bioreactor culture supplemented with PFC vs. the control.
However it should be noted that the scaffold was composed of mineral fibers coated with type
I collagen. This could be the pitfall of PFC emulsions in perfusion scaffold cultures. Unlike
Hollow Fiber or 2D bioreactors, which allows unfettered flow of PFC emulsions through the
extracapillary space or over a cellular monolayer respectively, the micro-porous structure of
a scaffold could be too small or random thereby hindering PFC passage through its interior
and nullifying its intended effect.
Perfluorocarbons, under the right experimental conditions can prove useful in
enhancing liver-specific functionality.

However from a true physiological perspective

hemoglobin-based oxygen carries (HBOC) would seem to be the better alternative. HBOCs
can increase oxygen solubility 70-fold over that of regular aqueous media vs. 10-fold for PFC.
Moreover HBOCs exhibit a binding/dissociation curve similar to that of RBCs and they
bind/release O2 in ranges that are physiologically relevant [200].
Albumin synthesis did not correlate well with Sakai et. al [200] for rat hepatocytes
cultured in perfusion with lipsome-encapsulated hemoglobin (LEH) supplemented media.
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Although data is only reported for the first 24hr the culture exhibited rates of ~45 ug/105
cells/day vs. this study which reported 11.797 ug/million cells/day on day 1. In a follow-up
study which extend the culture duration to 4 days, rates from adult rat hepatocytes exceeded
40 ug/million cells/day on day 2 of the culture. This value was halved for fetal rat hepatocytes
under similar culture conditions. These results are contrary to conventional data in that fetal
hepatocytes tend to be more functional than their adult counterparts. However LEH could
have an adverse effect on less mature hepatocytes. Despite the gap in albumin protein
synthesis there is a slight trend in that production decreases as the culture progresses. This
being true-to-form form for most hepatocyte cultures.
Chen and Palmer [184], with a hollow fiber bioreactor reported rates ranging from 0.4
- 0.8 ug/hr/106 cells. Activity was maintained for at least 2 weeks. In this study (3rd generation
reactor) hepatocytes seeded chitosan scaffold with direct and convective oxygenation were
also able to maintain hepatic viability and protein synthesis for the duration of the culture
albeit at lower levels (4.6 – 9.589 ug/106 cells/day). It is believed that the discrepancy in
functionality is attributable to poor oxygen solubilization in aqueous media. It could also be
further postulated that because auxiliary oxygen is being added to the system by way of the
gas permeable tubing, there is a chance that excess oxygen could have caused mitochondrial
free radical oxygen species formation and contributed to further loss of function.
When comparing the results from the two HBOC groups it’s clear that Sakai et al
outpaced the later even though both cultures contained a form of HBOC. This could be due
to the fact that free hemoglobin (Hb) outside of red blood cells can be toxic because of high
redox activity which can lead to reactive oxygen species generation and subsequent cellular
damage [201]. The liposome-encapsulated Hb, the formulation used by the Sakai group,
prevents free Hb leakage - which could account for increased functionality.
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Studies that utilized hemoglobin-based oxygen carriers (HBOCs) or perfluorocarbons
(PFC) did not evaluate ureagenesis as a metric for hepatic functionality. For this reason
ureagenesis results from this study were not mentioned in this section.
3.5

Conclusion and Future Work
In this chapter the feasibility of improving the viability and hepatocellular functionality

by optimizing the bioreactor design and culture conditions has been demonstrated. Factors
such as media acidification, improved bioreactor design, and convective and direct
oxygenation contributed to increased hepatic metabolic output. When compared to reported
data from previous studies in our lab, the final system in this study exhibited better
performance over a seven day culture period.
The next chapter will utilize computational fluid dynamic simulations to investigate the
influence that varying inlet volumetric flow rates have on hepatocyte oxygen uptake, fluid flow
characteristics around and between the entrapped cellular aggregates and shear stress
imposed on these cells. The shear stress and oxygen concentration along the length of the
scaffold will be elucidated. These parameters in conjunction with the flow characteristics will
be used to better understand the scaffold/cellular micro-environment under perfusion. It is
believed that achieving and understanding this information will help to further optimize our
culture conditions and improve hepatocyte functionality.
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CHAPTER FOUR: COMPUTATIONAL FLUID DYNAMICS
ASSESSMENT OF HOW MASS FLOW RATES AFFECT FLUID FLOW
PROFILES, SHEAR STRESS AND OXYGEN CONSUMPTION IN A
CELL-INFUSED MICROENVIRONMENT
4.1 Introduction
There are many factors that have to be addressed before an “off the shelf” tissue
engineered construct can be successfully seeded with the appropriate cell type configuration,
cultured under optimal conditions and seamlessly integrated into the human body.

Such

factors include bioreactor and scaffold design, scaffold location, initial flow rates and mass
transport attributes [202]. These factors have been explored as a “Black box” with random
assumptions and iteratively-derived empirical data which has proved to be very costly, time
consuming and mentally taxing. More importantly such approaches have led to inconclusive
or incorrect results that inevitably lead to in-vitro graft and/or host/graft failure. Over the last
two to three decades researchers have looked to computational fluid dynamics (CFD) or
computer-aided mathematical models as a tools to help guide the discovery process by
addressing and subsequently mitigating the number of unknowns pre- in-vitro.

The

advantage that CFD offers is that it allows for the prediction, comprehension and
characterization of certain phenomenon (i.e. fluid flow, consumption/secretion kinetics and
hydrodynamic stress profiles, spatial and temporal cell seeding distribution, and volumetric
and mass flow rate estimates) that are occurring within and around the scaffold/bioreactor
complex at the macroscopic and microscopic scales.
One of the earlier publications that utilized computational fluid dynamics as a
precursor to their experimental works was by Block and Talalla [203]. Although rudimentary
in comparison to today’s CFD models they, with a set of seven assumptions, were able to
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further their understanding of derangements of cerebral spinal fluid (CSF) dynamics which
helped to shed light on symptomatic low-pressure hydrocephalic states in man. Since then
CFD and computational biological modeling has been integrated into just about every facet
of basic medical research. It been utilized in research fields such as tracheobronchial air
flow/particulate transport motion [204, 205], vascular remodeling [206, 207], hemodynamics
[208-210] and tissue engineering [211-213]. Recently Guyot et. al [214] recently utilized CFD
to elucidate the shear stress magnitude and distribution along the fluid/neo-tissue boundary
during growth. The 21-day experimental validation culture was carried out with Ti6Al4V
Scaffolds seeded with Human Periost-Derived Cells (hPDCs). From their work they were
able to discern that there is a significant difference in shear stress imposed on the cells at the
fluid interphase vs that seen on cells within their porous construct. They were also able to
elucidate how pore geometry affected that magnitude of mechanical stress during culture and
neo-tissue formation.
Hepatic tissue engineering has benefited tremendously from computational fluid
dynamic and computer aided mathematical modeling. These simulation tools have proven to
be a critical adjunctive measure to empirical data generation for predicting bio-physiological
phenomena such as hydrodynamic stress [215, 216], metabolic function [215, 217], the
effects of oxygen carries on oxygen transport [218-220] and oxygen consumption [221-224]
within the scaffold/cellular microenvironment in invitro and invivo settings. Debbaut et al.
developed a numerical and CFD model to simulate complex micro-circulatory blood perfusion
from the macroscopic level to the sinusoidal terminal unit in a healthy liver. Using vascular
corrosion casting with high resolution micro-CT, a 3D image-based of the liver vascular was
rendered and used to study fluid mechanical properties during sinusoidal perfusion. From
this unique model of the of the lobule unit which had the z-axis parallel to the liver central vein
they were able to ascertain pressure, flow resistance and permeability tensor differences in
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the z-direction from those in the r and θ-directions. From the study it was concluded that the
immediate result of these findings was that the sinusoidal circulation behaves in an
anisotropic manner. Moreover they also pointed out the deficiency in their model in that it the
shear stress levels generated did not fully reflect that of what is seen in vivo. Conversely,
they more resemble what is seen from a machine perfused organ before transplantation [216]
. This work was followed up by Peters et. al [225] who used the same vascular corrosion
casting with high resolution micro-CT and computational fluid dynamics to study the microperfusion and permeability in a cirrhotic liver. They were able to show that anisotropic
permeability within a cirrhotic liver was highest in the direction parallel to the central vein and
lower values were in the radial and circumferential direction. Their macro-circulation model
also indicated that regenerative nodules within the cirrhotic liver increases intrahepatic
vascular resistance beyond 65 vol.%. of the regenerative nodules.
Despite the advances that CFD and computer aid numerical modeling have made
toward understanding metabolic and fluid flow phemena within the scaffold/cellular
microenvironment the internal flow, hydrodynamic and oxygen consumption profiles of certain
micro-structures impregnated with single and multi-cellular masses still lacks a certain level
of understanding.

With the use of well-defined engineering principles, we are able to

approximate certain flow characteristics at localized regions within our porous construct.
What is also not understood in our cultures is how the change in internal flow rates at the
inlet, which affects oxygen consumption and the mechanical stress imposed on the cells,
correlates with overall cell health based on experimentally derived parameters. To gain
insight into the in vitro hydrodynamic stress and oxygen concentration distribution, and fluidic
microenvironment, in this study a small segment of the cell seeded porous construct was
designed and meshed, and simulated with the ANSYS GAMBIT and FLUENT software
packages respectively. In this model oxygen consumption/availability, shear stress and fluid
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flow were analyzed at varying inlet flow rates.

The parameters for hepatocyte oxygen

consumption (VM and KM) and culture medium pO2 parameters were obtained from literature
values that were experimentally derived. To simplify the simulation the culture medium took
on the characteristics of water and modeled as an incompressible, isothermal, Newtonian
fluid.
4.2 Materials and Methods
4.2.1 Computer Model of Hepatocyte-Infused Porous Scaffold
The inspiration and thought process that brought about the geometry that simulated
the multi-cellular aggregated infused interconnected porous structure can be seen in Figure
20. The geometry modeling and grid generation (i.e meshing) were both conducted with the
software package GAMBIT (ANSYS, Concord MA). In addition to fluid flow and hydrodynamic
stress profiling, part of the rationale behind the geometry was understand how oxygen
consumption of the cells adjacent to the central port affected oxygen availability and
subsequent functionality and viability, of cell downstream without the support of direct oxygen
supplied by the impregnated gas permeable tubing. Essentially the simulation and generated
data only pertains to cells positioned between and not assisted by direct oxygenation
facilitated by the gas permeable tubing. The modeling and mesh generation could have been
expanded to accommodate the full scale scaffold however to reduce computation time to
convergence and computing expenditures the geometry was reduced to the interconnectivity,
cell seeding and fluid trajectory that stems from a single pore in the scaffold’s central port
region to its outlet at the scaffold’s perimeter.
The pore size corresponding to the central port was 400µm. The height and length
of the porous geometry was 100um and .75cm respectively. The size of the inlet pore and,
the pore height and length were derived from the actual scaffolds used in the experimental
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bioreactor cultures. The conditioned medium that we assumed to be equilibrated to the
gaseous atmosphere created by the oxygenator entered the structure through the single pore
inlet. A constant normal velocity profile was set as the boundary condition at the fluid inlet.
The oxygen concentration at the pore inlet was also set to be constant at 21 mol/m3. The
medium perfused through the porous zones while making contact with every aggregate on all
sides. The culture medium exited the porous geometry through 64 significantly smaller pores
all of which have an “outflow” boundary condition set at zero pressure.
The tapered pores structure or channels from the inlet port to the scaffold periphery
was created by the sequential bifurcation of contiguous segments within the scaffold interior.
Each bifurcation doubled the number of pores in the subsequent segment. Spheroids were
incorporated into each pore to simulate multiple aggregated cell masses. Each aggregate
was design to occupy a significant majority of the pore volume. The geometry was meshed
using a tetrahedral protocol and “WALL” boundary conditions were assigned to the pore walls
and to the outer surface of each spheroid. The “WALL” boundary condition for the spheroids
and pore walls were also coupled with non-slip boundary conditions at the solid-fluid
interphase. The inlet mass flow rates were determined by experimental volumetric flow rates
and the assumption of equal-distribution of flow between each pore of the central port. Lastly,
the simulation was conducted using single precision, segregated solver.
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Figure 20: Rationale, workflow and final rendering for cell-infused pore structure for CFD
simulations
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4.2.2

Modeling Fluid Flow
To simulate fluid flow, the commercial computational fluid dynamic (CFD) software

pack Fluent 15.0 (ANSYS, Concord MA) was implemented to solve the velocity field by using
the Navier-Stokes equation for a incompressible, isothermal Newtonian fluid. Equations 1
and 2 represent the mass and momentum conservation equations.
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denotes density of the culture medium,
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the volume are represented by . For Newtonian fluids a component of the latter equation
includes the stress tensor Ƭ.
The stress tensor T is given by:
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is the molecular viscosity and is the unit tensor. Lastly the second term within the

brackets represents the effect of volume dilation.
The shear stress on the surface of each aggregate structure is dependent on the
density and viscosity of the culture medium. In general shear stress is proportional to the
rate of change of the shear strain Sxy, with the components of tensor Sxy given by the equation
below, and
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However in the Ansys Fluent solver when the mesh is fine enough to resolve the viscositydominated sublayer, the wall shear stress is obtained from the laminar stress-strain
relationship:
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,

is the shear velocity, - is the distance from the

wall, . is the von Karman constant (.4187), and + = 9.793. The culture media was modeled
with a density of 1000 kg/cm3 and a dynamic viscosity of 1x10-3 kgm-1s-1. The inlet mass flow
rates were applied at the entrance of the porous structure. The outlet boundary condition
was set to a zero pressure outflow and the barriers that made up the interconnected porous
structure, including top, bottom and side enclosures, and the spheroids that simulated the
hepatocyte aggregates were give the designated boundary condition of “no-slip” walls.
4.2.3 Modeling Species (Oxygen) Transport and Consumption
To simulate species/oxygen transport and uptake, Fluent solved the steady-state
equations (Eq. 7 and Eq. 8) for the convection and diffusion processes that involves dissolved
oxygen in our media.

( 34) + ∇ ∙ (

34) = −∇ ∙ 54 + 64

(7)

where

54 = − 74, 9 (∇34)

(8)

In Equation 7, 34 represents that local mass fraction of each species 4. 64 is the net rate of
production of species n by chemical reaction. 54 in Equation 8 represents the diffusion flux
for species 4 and 74, 9 is the mass diffusion coefficient for species 4. In the simulations
species consumption only occurred at the surface of the “WALL” boundary conditions that
were assigned to the surfaces that formed the cell aggregates. The ANSYS Fluent software
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models this type of reaction as a “wall surface reaction” which is governed by the general :;h
equation:
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represent the gas phase species, the bulk solid species and the surface

absorbed (or site) species, respectively. MN , MO , MP are the total number of these species.
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are the stoichiometric coefficients for each reactant species I, and
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are the stoichiometric coefficients for each product species i. Q? is the overall forward

reaction rate constant. In Equation 9 only the species involved as reactants or products
will have non-zero stoichiometric coefficients. All species not involved in the reaction will drop
out of the equations.
Oxygen consumption by the structures that simulated primary rat hepatocyte
aggregates inside the porous construct was modeled by the additional user-defined function
(UDF) term based on Michaelis-Menten kinetics (Eq. 10). The UDF was only implemented
on the surface “WALLS” of the aggregate structures.
RS
R

= −
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where Vmax is the maximum volumetric oxygen consumption (mol • s-1 • cell-1), Km is the
Michealis-menten constant corresponding to the oxygen concentration at which consumption
drops to half of its maximum, M\]^^ is the number of cells per aggregate and

RS
R

is oxygen flux

at the cell surface.
To realistically describe the oxygen consumption and hydrodynamic conditions within the
scaffold/bioreactor complex, several key elements and assumptions had to be factored into
the CFD simulation:
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i.

Equal flow and cell seeding distribution through each inlet pore in the experimental
scaffold’s central port region.

ii.

Cell number (Ncell) per aggregate in each segment of the structure was determined by
the percent volume of the segment in relation to the volume of the whole structure
divided by the number of aggregates in the segment.

iii.

Inlet pore velocity for CFD simulation is determined by the volumetric flow rate at the
central port (experimental) divided by the number of pores in the central port region.

iv.

At any given point along the length of the scaffold XY2 > Y2 (2 x 10-2 mol/m3) which
is the concentration at which hepatocytes are deemed non-functional due to hypoxia
[170]

The parameters used in the simulations are experimentally derived from rat hepatocytes.
These parameters can be seen in the Table 1.
Table 1: Parameters for computational fluid dynamics (CFD) model at 37°C
Parameter
Symbol
Value
Units
Ref.
Inlet O2 concentration
.21
mol/L
[226-228]
in
_`
D O2, aq
O2 diffusivity in aqueous
3x10-9
m2/s
[226, 227, 229]
media
Medium Viscousity (water)
µ
1.0x10-3
Kgm-1s-1
Medium Density
ρ
1,000
kgm-3
-17
Vmax
Max Hepatocyte
4.8x10
mol•s-1•cell-1
[230]
Consumption Rate
Km
7.39x10-3
Michaelis-Menten Constant
mol/L
[222]
Bioreactor Inlet Flow Rates
n/a
5, 10, 15
mL/min
n/a
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Table 2. Mesh element parameters for the number of cells and cell aggregates per pore
segment
Pore
# of mesh Vol. of
Aggregate
# of aggregates # of cells per
segment

elements

Elements

surface area

per segment

aggregate

1

3910

1.99E-13

1.03E-07

1

343

2

6628

1.98E-13

1.18E-07

2

196

3

5000

2.27E-13

1.09E-07

4

118

4

3912

1.85E-13

9.13E-08

8

95

5

3746

1.11E-13

5.86E-08

16

43

6

2994

8.30E-14

4.18E-08

32

20

7

1186

3.61E-14

1.84E-08

64

9

4.2.4 CFD Simulation Workflow
Each computational fluid dynamic simulation was carried out in two stages. The first
stage involved solving equations 1 and 2 which are the mass and momentum conservation
equations respectively.

From here we were able to assess the hydrodynamic stress

distribution and fluid flow profile with the pore structure. Simulations were conducted at the
mass flow rate values of 3.68x10-6 g/s, 6.737x10-6 g/s and 1.01x10-6 g/s which correspond to
the experimental culture flow rate values of 5, 10 and 15 ml/min respectively at the scaffold
central port inlet.
After the solutions for the stead-state equations were obtained, a second simulation was
run to solve for the species transport and Michaelis Menten equations. All three simulations
assumed that the full scaffold was seeded with 1 x 108 cells and these cells were distributed
evenly into each pore within the scaffold’s central port. Table 2. provides a list of the detailed
parameters that were utilized in the oxygen consumption simulations. This segment of the
simulation provided information about the oxygen uptake and distribution along the length of
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pore structure. This simulation was conducted for each experimental flow rate. It should be
noted that only shear stress data was generated for 1.47x10-5 g/s and 1.84x10-6 g/s which
corresponds to the central port inlet volumetric flow rate of 20 ml/min and 25 ml/min. The
reason for this decision was our mass transport expectations were exceeded at the lower flow
rates and the shear stress thresholds at these volumetric flow rates were surpassed. In total
higher volumetric flow rates would extend the dynamic range of higher concentrated oxygen
supplied to the cells, however these higher flow rates imposed shear stresses that would
render the cell non-viable and not able to take advantage of the oxygenated environment.
4.3

Results

4.3.1 Computational Fluid Dynamics Results for Fluid Flow and Velocity Profile
Figures 21 to 23 shows and compares the results from the steady-state simulation
results for the cell-infused tapered pore construct with the inlet mass flow rates of 3.36x10-6
g/s, 6.737x10-6 g/s and 1.01x10-5 g/s, which corresponds to the experimental volumetric flow
rates of 5 ml/min, 10 ml/min and 15 ml/min, respectively at the scaffold’s central port inlet.
The arrows illustrate the fluid flow profile and velocity vector distribution. The side, top,
bottom and internal pore walls were omitted from the images to better display the transitional
differences in vector magnitude along the length of the structure. Fluid velocity is illustrated
by color with red denoting areas of high velocity and dark blue for areas of zero flow. Also
images of porous structure were taken only from the first three aggregate segments as these
were the regions of high fluid flow. The maximum and minimum velocities for 5, 10 and 15
ml/min were .0007 - .0028 ft/s, .0010 to .0040 ft/s, and .0010 to .0040 ft/s respectively. High
velocity flow for each flow rate was typically in the area near the inlet of the pore structure
and progressively decreased as flow moved towards the outlet. However in the tight spaces
between the cellular aggregates and the pore walls there are abrupt changes in fluid velocity.
In these areas the fluid velocity doubles in comparison to scaffold segments without
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aggregates. This was consistent for each simulated condition. In all simulated conditions
flow was not halted based on the pore volume occupied by the aggregates. Lastly, the
simulation showed that fluid recirculation around or after each aggregate segment was not
an issue.
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Figure 21: Velocity vector distribution and fluid flow profile through the first 4 bifurcating
segments from the pore port inlet for the mass rate of 3.36 x10-6 g/s, which corresponds to
the volumetric flow rate of 5 ml/min at the scaffold’s central port inlet
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Figure 22: Velocity vector distribution and fluid flow profile through the first 4 bifurcating
segments from the pore port inlet for the mass rate of 6.737 x10-6 g/s, which corresponds to
the volumetric flow rate of 10 ml/min at the scaffold’s central port inlet

77

Figure 23: Velocity vector distribution and fluid flow profile through the first 4 bifurcating
segments from the pore port inlet for the mass rate of 1.01 x10-5 g/s, which corresponds to
the volumetric flow rate of 15 ml/min at the scaffold’s central port inlet
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4.3.2 Computational Fluid Dynamics Results for Wall Shear Stress
Hepatocyte function, in perfusion cultures, is negatively modulated by the presence of
excessive shear stress.

In the simulation we assessed shear stresses for values that

correspond to experimental flow rates 5, 10 and 15 ml/min at the central port inlet. Since
shear stress is directly related flow velocities, in general shear stress at the wall intensified
as the inlet flow rate increased for each simulation. However within each simulation, the
shear distribution from inlet to outlet were inconsistent. We saw that elevated shear stresses
were located at the pore inlet and decreased somewhat uniformly towards the outlet. This
can be attributed to the reduction of the flow caused by tapered bifurcated segments of the
pore geometry. The shear stress values exhibited in Figures 24 to 26, for each flow rate
ranged from .21 Pa (2.1 dynes/cm2) to .017 Pa (.17 dynes/cm2) at 5ml/min, .027 Pa (2.7
dynes/cm2) to .35 Pa (3.5 dynes/cm2) for 10 ml/min and .45 Pa (4.5 dynes/cm2) to .035 Pa
(.35 dynes/cm2) at 15ml/min. The side, top and bottom walls of the pore structure were
omitted from the shear stress images to better display the contour gradients. It should be
also noted that the wall shear stress values imposed on the aggregate surfaces, in all three
simulations, did not exceed the threshold value for compromised cell functional as put forth
by Tilles et. al at 5 dynes/cm2 [192]. This would indicate that the cells, at least on the outer
surface of each aggregate, were not adversely impacted by the shear stress generated by
the experimental flow conditions.
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Figure 24: Contour plot of flow induced shear stress distribution imposed on cell aggregate
surfaces through the first 4 bifurcating segments from the pore inlet along the axial length of
the porous construct. The simulation was conducted at a mass flow rate of 3.36 x10-6 g/s
which corresponds to the experimental volumetric flow rate of 5 ml/min at scaffold central port
inlet.
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Figure 25: Contour plot of flow induced shear stress distribution imposed on cell aggregate
surfaces through the first 4 bifurcating segments from the pore inlet along the axial length of
the porous construct. The simulation was conducted at a mass flow rate of 6.737 x10-6 g/s
which corresponds to the experimental volumetric flow rate of 10 ml/min at the scaffold central
port inlet.
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Figure 26: Contour plot of flow induced shear stress distribution imposed on cell aggregate
surfaces through the first 4 bifurcating segments from the pore inlet along the axial length of
the porous construct. The simulation was conducted at a mass flow rate of 1.01 x10-5 g/s
which corresponds to the experimental volumetric flow rate of 15 ml/min at the scaffold central
port inlet.
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Partial simulations were also conducted for mass flow rates 1.47x10-5 g/s and 1.84x105 g/s

which corresponds to the volumetric flow rate of 20 and 25 ml/min at the scaffolds central

port inlet.

The full gambit of simulations comprising of oxygen consumption was not

conducted for these rates as hydrodynamic stress imposed of the cells aggregates in each
segment exceeded 5.0 dynes/cm2, which has been documented as the threshold for
compromised hepatocyte functionality. From the shear simulations at 1.47x10-5 g/s the shear
stress values ranged from .024 - .982 Pa (.24 – 9.82 dyne/cm2) at the port inlet to the construct
midpoint and .073 - .894 Pa (.73 – 8.94 dyne/cm2) from the midpoint to the periphery. From
Figure 27 it is clearly evident that every aggregate in each segment is experiencing flow
induced stress over 5.0 dynes/cm2 with first two aggregate segments seeing this value or
higher on more that 50% of its surfaces. The level of shear does subside towards the middle
of the construct but increases towards the periphery with aggregates in segments 5, 6 and 7
experiencing levels at or over the threshold of 5.0 dyne/cm2 on a third of their surfaces.
Similar trends, but at higher shear levels, were exhibited for the simulation at 1.84x105 g/s.

At the pore inlet to midpoint of the construct the shear stress levels ranged from .048 –

1.247 Pa (.48 – 12.47 dyne/cm2) and .036 – 1.224 Pa (.36 – 12.24 dyne/cm2) from the
midpoint to the periphery. From Figure 28 every aggregate in each segment, except the third,
have shear stress at or greater than 5.0 dynes/cm2 on more than 50% of its surfaces. In fact
aggregates in the first two segments are showing shear levels that exceed the
aforementioned threshold on more than two-thirds of their surfaces. If validated, these results
would suggest that in an experimental setting, more than 66% and 50% of hepatocytes,
located on the aggregate surfaces, would succumb to shear mediated apoptotic death at the
pore inlet and mid-to-periphery respectively.
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Figure 27: Wall shear stress levels of aggregate containing segments at the mass flow rate
of 1.47x10-5 g/s (20 ml/min)

Figure 28: Wall shear stress levels of aggregate containing segments at the mass flow rate
of 1.84x10-5g/s (25 ml/min)
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4.3.3 Computational Fluid Dynamics Results for Oxygen Consumption
Figures 29, 31 and 33 provide the steady state contour profile of O2 consumption and
concentrations for each simulated mass flow rate condition. Moreover the figures shows how
oxygen consumption occurred around the cell aggregates and, based on aggregate number
and cell number per aggregate. Oxygen concentration is shown by color gradient, with the
red representing areas of higher concentration and dark blue signifying regions of zero
oxygen.

In addition to oxygen uptake distribution Figures 30, 32 and 34 also provide

information about where transitional changes in oxygen uptake occurred along the axial
length of the construct.
The impact that flow rate had on mass transport and oxygen consumption was very
evident when comparing all three simulations. The contour plots in Figures 29, 31 and 33
show a less gradual color gradient change in oxygen concentration as the simulated inlet
mass flow rates increase from 3.68x10-6 g/s (5 ml/min) to 1.01x10-5 g/s (15 ml/min). Table 3
also shows the gradient flux in each cell aggregate containing segment decreases with
increased inlet flow rates. When comparing 3.68x10-6 g/s (5 ml/min) to 1.01x10-5 g/s (15
ml/min) the average change in each segment was ~3-fold except in the second segment
where there was a ~4-fold change. When contrasting 6.737x10-6 g/s (10 ml/min) and 1.01x105 g/s

(15 ml/min) the majority of segments saw a 2-fold change, except for segments one and

six. Both of which saw a 1.5-fold change.
The effects of flow rate on oxygen consumption is further supported by the percent
change of oxygen consumption per aggregate containing segments. From Table 4 we can
see that in the first segment of cells, which happens to have the largest cell density, the
percent change in oxygen consumed decrease by 3-fold when the lowest and highest inlet
flow rates are compared. The same can be said for the next two successive segments where
the changes are ~5-fold and ~4-fold respectively. The fifth cell segment is where the most
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drastic shift can be seen between the highest and lowest rates. Here there is an exact 9-fold
difference in the percent change in oxygen consumption. The last two segments could not
be quantified in this manner as the oxygen concentration at the mass flow rate of 3.68x10-6
g/s was zero.
By increasing the inlet flow rate we were able to improve oxygen transport, and one
could deduce nutrient transport as well, to cells at the midpoint and more towards the
periphery of the construct. If the first simulation at 3.68x10-6 g/s (5 ml/min at the actual
scaffold central port inlet) is used as a baseline, as we increased the flow rate to 6.737x10-6
g/s (10 ml/min) and 1.01x10-5 g/s (15 ml/min) oxygen availability increased by 42 and 100%
at the construct’s midpoint and, 51 and 100% at the periphery respectively. 100% was
reported for both flow rates at the periphery because oxygen availability, assessed by
reported concentration, for the baseline condition was zero. When the 6.737x10-6 g/s (10
ml/min) and 1.01x10-5 g/s (15 ml/min) mass flow rates are compared, the oxygen availability
increased by 15% at the midpoint and 52% at the periphery for the latter. Of the three
simulations, the lowest mass flow rate was the only condition in which oxygen concentration
fell below the threshold for compromised functionality (2 x 10-2 mol/m3) by hypoxia. Based
on Figure 30 this occurred at .575 cm into the construct, which would indicate that cells
residing in the last 29% of the scaffold’s interior were cultured in a hypoxic environment.
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Figure 29: Contour plot of steady state oxygen distribution along length of porous structure
with infused cell aggregates. Simulation was conducted at mass flow rate of 3.36 x10-6 g/s
(5 ml/min at scaffold central port inlet) with a constant oxygen inlet concentration of .21 mol/L.
Dark blue color indicates hypoxic regions where X_` < _`
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Figure 30: Oxygen concentration profile along the axial length of the porous construct at inlet
mass flow rate of 3.36 x10-6 g/s (5 ml/min at scaffold central port inlet) with a constant oxygen
inlet concentration of .21 mol/L

Mass
Segment
Flow Rate 1 (1/343)
(g/s)
(450um)

Segment
2 (2/196)
(400um)

Segment
3 (4/118)
(500um)

Segment
4 (8/95)
(700um)

Segment
5 (16/43)
(500um)

Segment
6 (32/20)
(400um)

Segment
7 (64/9)
(400um)

3.86x10-6

-0.67

-0.88

-0.70

-0.86

-0.90

n/a

n/a

6.737x106

-0.33

-0.38

-0.40

-0.43

-0.60

-0.63

-0.62

1.101x105

-0.22

-0.20

-0.24

-0.29

-0.32

-0.40

-0.38

Table 3: Concentration flux (gradient) across the length of cell aggregate(s) per sequential
segment. Units for gradient values are in (mole/L)/cm. The values in the parenthesis
represent the number of cell aggregates in the associated segment followed by the number
of cells per aggregate. The second set of parenthesis contains the aggregate length in um.
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Figure 31: Contour plot of steady state oxygen distribution along length of porous structure
with infused cell aggregates. Simulation was conducted at mass flow rate of 6.737 x10-6 g/s
(10 ml/min at scaffold central port inlet) with a constant oxygen inlet concentration of .21
mol/L.
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Figure 32: Oxygen concentration profile along the axial length of the porous construct at the
inlet mass flow rate of 6.737x10-6 g/s (10 ml/min at scaffold central port inlet) with a constant
oxygen inlet concentration of .21 mol/L

Mass Flow Segmen
Rate (g/s)
t 1 (1 /
343)

Segmen
t 2 (2 /
196 )

Segmen
t 3 (4
/118)

Segmen
t 4 (8
/95)

Segmen
t 5 (16
/43 )

Segmen
t6
(32/20)

Segmen
t7
(64/9)

3.86x10-6

14.20%

19.40%

24.10%

54.50%

90%

n/a

n/a

6.737x10-6

7.10%

8%

11.10%

19%

23%

25%

33.30%

1.101x10-5

5%

4%

6.25%

11.10%

10%

11%

12%

Table 4: Percent change in oxygen consumption per successive aggregate(s) containing
segment. The values in the parenthesis represent the number of cell aggregates in the
associated segment followed by the number of cells per aggregate. n/a means that oxygen
concentration at that segment was zero
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Figure 33: Contour plot of steady state oxygen distribution along length of porous structure
with infused cell aggregates. Simulation was conducted at mass flow rate of 1.01 x10-5 g/s
(15 ml/min at scaffold central port inlet) with a constant oxygen inlet concentration of .21 mol/L
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Figure 34: Oxygen concentration profile along the axial length of the porous construct at inlet
mass flow rate of 1.01 x10-5 g/s (15 ml/min at scaffold central port inlet) with a constant
oxygen inlet concentration of .21 mol/L
4.4

Discussion

Computational fluid dynamic models have provided much needed insight into how
external stimuli influence cellular processes in fluidized, three dimensional microenvironments. In this study we reconstructed our cell seeded, porous chitosan scaffold,
at the single pore level, to predict how flow, at varying magnitudes, effects oxygen
consumption and availability experimentally. Furthermore the CFD model was used to
provide

insight

about

the

flow

characteristic

within

our

hepatocyte/scaffold

microenvironment and to predict the hydrodynamic forces imposed on these cells in vitro.
The overarching goal of this work was to use the information garnered from these
simulations to help predict cellular outcomes pre-culture and to optimize the experimental
design process.
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The geometric rendering of the cell infused scaffold and CFD model are felt to be
good representations of our experimental scaffold. The porous structure of the model
accurately represents that of our scaffolds due to inlet pore sizes match (high end for
scaffold at 400 µm), and both pores structures are radial and linear, tapered and
interconnected. Although not measured, but from a qualitative perspective both have
similar tortuosity. Also similar to our in vitro system, the aggregates in our model occupy
a significant amount of the pore volume. The rationale for incorporating aggregates was
that they more accurately resembles our scaffold/hepatocyte complex which in turn will
better predict the internal flow patterns of media in and around our cells which affect
velocity and shear distribution, and oxygen consumption. From the CFD simulations we
were able to show how velocity progressively decreased along the axial length of the
scaffold in the segments between the aggregates. The decrease in velocity was mostly
attributed the bifurcating nature of the tapered interconnected porous structure. The velocity
vector distribution for each mass flow rate condition showed that fluid flow in the structure
was laminar. The vectors also showed that flow, mainly due to a low mass flow rate at the
pore inlet, was orderly with essentially no eddies or swirls which would suggest that the
Reynolds number for each simulation, along the length of the construct was under the
threshold that would transition laminar to turbulent flow. This would also suggest that media
was able to travel the distance of the scaffold and that the transportation of nutrients and
oxygen to cells was not disrupted.

However it should be noted that there was slight

recirculation at the pore inlet for the mass flow rate of 6.737-6 g/s (10 ml/min) condition but
this was resolved before the fluid reached the first aggregate. The magnitude and color of
the velocity vector arrows would indicate that the flow profile, despite the aggregates, still
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followed a typical parabolic shape for laminar flow in that the velocity at the pore walls was
zero.

Shear or hydrodynamic stress at certain magnitudes is beneficial to some cells and
essential to others such as endothelial cells that line our vasculature system. However
at certain levels, which are cell type dependent, shear stress can disrupt essential cellular
processes and produce calamitous effects. In dynamic scaffold culture, predicting shear
stress levels inflicted on the cells along the fluid trajectory in the matrix is virtually
impossible. What can be simply said is that levels increase with increasing flow rates.
Understanding or being able to predict, with confidence, the shear stress level within a
matrix’s microenvironment could be the difference between device success and failure.
In this study we utilized computational fluid dynamic simulation to ascertain shear stress
levels within our scaffold microenvironment and extrapolated these finds to elucidate the
shear effects on our hepatocytes. According to our computational results, shear stress
for the three lower flow rates remained below the needed threshold. However the mass
flow rates of 1.47x10-5 g/s (20 ml/min) and 1.84x10-5 g/s (25 ml/min) produced forces that
were well above this threshold and would have been deemed as unsafe perfusion culture
conditions. Shear stress is a proportional to the velocity magnitude and what was noticed
from our model is that velocity doubled in the tight spaces around the aggregates in
relation to previous sections without aggregates. This perfectly logical as shear forces
increase with decreased flow area. This would indicate that shear flow distribution, if flow
is not occluded, is dictated by aggregate position and how much of the aggregate
occupies the scaffold void volume. In an in vitro setting where spatial distribution of cell
aggregates can only be partially controlled (pore size and direction) the flow and
subsequent shear force distribution would not be consistent throughout which is in
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agreement with this model. For these reasons it is felt that model is a good predictor of
the magnitude of stress internally.
Others have used CFD simulations to predict shear stress levels imposed on their
cells in culture. For those whose cells are cultured in monolayers [231-234] it is feasible
to assume that cell layer in contact with fluid is flat and can be modeled as the surface of
the planar surface of the perfusion reactor and given a “WALL” boundary condition.
However for bulk 3-D scaffold models who experimental cultures utilize high cell densities
but assume that this aspect’s contribution to the system’s shear profile is insignificant, it
is felt that these models don’t accurately represent the microenvironment and will
generate unreliable data. Using a dynamic cell growth model Lesman e. al [235] was
able to show how shear stress distribution is effected by increasing cell densities.
Lesman’s demonstrated that occlusion of the flow field, in this case, by escalated cell
compaction which reduced the scaffold void volume, increased the level of shear
experienced by the surfaces of the cells in the fluid path. Melchels et al. [236] also
described the impact that cell dispersal and relative densities have on the magnitude and
spatial distribution of shear stress in fluidized scaffold. In the CFD model, Mechel’s type
G scaffold configuration showed that by increasing the relative cell density by 20% the
average shear stress increased 3-fold. The model also demonstrated that past 30%
relative cell density shear stress levels plateaued. The model was not pushed passed
75% relative cell density. It is speculated that convergence issues with the simulation
could have or did pose an issue.
Oxygen transport limitations have always posed serious problems for cells seeded
in bulk scaffold constructs. The solution of increasing fluid flow to increase the transport
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distance of oxygen is no longer a rationale nor viable solution. Thus it is important to the
success of a perfused tissue engineered device that the correct balance is struck between
increased mass transport efficiencies and damaging shear effects. In this segment of the
study we looked at how increasing inlet flow rates modulated shear stress and more
importantly oxygen transport distance within porous construct. From our results were we
able to show that within our scaffold, with the experimentally comparable cell densities,
increased flow does decrease the intensity of the consumption gradient along axial length
of our scaffold. A similar trends were seen by Cioffi et. al [237] who utilized a micro-CT
rendered scaffold to investigate how increased flow effected oxygen gradients along the
length of chondrocyte infused construct. It was discerned by increasing inlet flow rate
from .03 to .3 ml/min the percent oxygen availability could be increased by 26% at the
scaffold’s periphery.

Podichetty et. al [221] also demonstrated that the oxygen

distribution from the scaffold inlet to outlet could be increased by ~57% with a volumetric
flow rate increase from 1- 15 ml/min.
In establishing a volumetric flow rate (3.68x10-6 g/s → 5 ml/min at the scaffold
central port inlet) that can simulate medium flow from inlet to outlet while producing the
least amount of shear stress, what we saw in terms of oxygen consumption and
availability is that the last 29% (.575 cm away from inlet) of the scaffold that contained
cells was a hypoxic environment. This can be attributed to the increased residence or
interaction time of the oxygen molecules with the aggregate surface. Lawrence et. al
[238] explained that residence time distribution (RTD) is “a measure of dispersal of a
molecule in a flowing medium owing to the combined action of a velocity profile and
molecular diffusion”. In this scenario residence time is dependent on the fluid velocity
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and oxygen consumption rate. Devarapalli et. al [239] looked at how flow rates and
residence time distribution affected oxygen uptake distribution across 6 different cell
types. Essentially what he saw across all cell types is as you decrease the inlet flow rate,
residence time increase and oxygen availability decrease along the fluid flow trajectory.
In terms of hepatocytes, in his system the flow rate of 1ml/min increased the residence
time enough to where oxygen levels with, at the outlet, were zero. In a future but similar
experiment from the same lab, while using a hepatic model it was also concluded that
increased fluid flow at the reactor inlet produced better oxygen availability at the reactors
outlet [221].
4.5

Conclusion and Future Work
Computational fluid dynamic models used in this study provided needed information

about our scaffold’s microenvironment and how varying flow rates might impact shear stress,
oxygen consumption and fluid motion within its interconnected porous architecture. The
results presented in this study showed that under the right conditions the transport of key
nutrients to the entrapped cells would not be hampered by the porous nature of construct.
Moreover the models also demonstrated that under the two highest flow rates, oxygen
transport limitations, that are known to plague bulk scaffold constructs, and are exacerbated
by the highly aerobic nature of hepatocytes, can be overcome with minimal damage due to
shear effects. More importantly, for the scope of the objectives, the simulations showed that
the model is works. Just as important the study demonstrated that the model can be scaled
up to accommodate more clinically relevant cell densities and experimental input to help
predict how certain stimuli might influence cellular processes pre-in vitro and aid in the
optimization of future experimental designs.
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Understanding how closely the data generated from the CFD model correlates to the
actual in vitro experiment is just as important as the model itself. This would lend to the
model’s credibility and efficacy. That said in the following chapter perfusion bioreactor studies
with cell numbers and flow rates matching that of the model will be conducted to validate the
model predictions. It is hypothesized that the flow rate which produced the best oxygen
transport profile with shear stresses below the damaging threshold of 5 dynes/cm2 will
produce the best viability and metabolic outcomes.
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CHAPTER FIVE: EVALUATION OF HOW SHEAR STRESS AND MASS
TRANSFER AFFECT HEPATOCELLULAR-FUNCTIONALITY,
MORPHOLOGY AND VIABILITY: EMPIRICAL ASSESSMENT OF CFD
SIMULATIONS
5.1 Introduction
Shear stress is the hydrodynamic force induced by liquid-based friction against the
cell membrane. The mechanical stimulus, caused by shear stress, affects the cell-specific
and morphological behavior, and adhesion properties of several cell types in in-vivo and invitro. Depending on the cell type and function, shear stress can be deleterious or essential
to proper phenotypic expression.

Regarding the latter, shear stress imposed on the

endothelium has been shown to regulate vascular morphogenesis, atherosclerosis and blood
pressure. When acting directly on endothelial cells, shear stress inhibits apoptosis [240],
activates Ca2+ influx [241], triggers signaling cascades which modulate gene expression and
cytoskeletal remodeling by reducing cell contractility via decreased VE-cadherin tension and
increased tension on PECAM-1 [242]. Ueda et al. demonstrated that shear stress exhibited
a positive effect on odontogenic cells by upregulating the expression of both epithelial and
mesenchymal ondontogenic-related mRNAs after 2hrs of exposure, and increase protein
expression and better in-vivo integration after 12 hours of exposure when compared to the
control [243].
In-vivo hepatocytes are principally shielded from shear stress by vascular endothelial
cells. However past evidence suggest that hepatocytes do experience a certain level of direct
shear stress through small pores in the sinusoidal endothelium [244] or experience force
passively from being in contact with sinusoidal endothelial cells that are stretching due to
shear stress imposed by portal blood flow. This would suggest that shear stress or force, to
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some degree, is essential to normal hepatocellular functionality in-vivo. The effects of shear
stress, in-vivo, are further boosted after partial hepatectomy, where increased hemodynamic
forces imposed on hepatocytes are partially responsible for triggering cell proliferation [245].
Hepatocytes exposed to hydrodynamic forces that don’t exceed harmful threshold
values are known to produce greater rates of albumin and urea secretion in comparison to
static cultures. Kan et al. initially observed improved ammonia removal and ureagenesis in
hepatocyte co-cultures with nonparenchymal cells under shear stress [246]. Similar results
were observed by Yu et al. and Shuler et al. in uni-directional and bi-directional perfusion
reactors respectively [247, 248]. In both instances, and in similar cultures alike, elevated
hepatic performance is attributed to increased gas, nutrient and metabolite exchange which
is limited, from a mass-transport perspective, in static cultures. In addition to increased liver
specific function, shear stress, when moderately applied, inhibited liver tissue destruction
[249] and contributed to higher collagen secretion from hepatocytes [250].
Conversely data also suggest that moderate to excessive levels of shear stress can
prove to be quite detrimental to hepatocyte functionality over time. Although a definitive
threshold has yet to be established, most likely because certain bioreactor configurations
present shear differently, some have stated that at 5 dynes/cm2 activity begins to collapse
[192].

Sato et al. reported shear stresses greater than 1.0 Pa (10 dyne/cm2) caused

hepatocytes to assume a morphology analogous to endothelial cells which negatively
influenced their metabolic capacity when culture periods exceeded 3 days [251]. However
others have reported enhanced cytochrome P-450 monooxygenase, P-450IA1 (CYP1A1)
expression in response to higher hydrodynamic stress [252].
A viable bioreactor/scaffold complex necessitates adequate convective mass
transport as hepatocytes are highly metabolic and sensitive to oxygen concentrations. In
perfusion systems where hepatocytes are not shielded from shear by encapsulation (i.e.
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alginate or endothelial cells) and flow is parallel to all hepatic surfaces and deemed nonphysiological, a delicate balance between flow rate, which facilitates good mass transfer and
shear stress, must be adhered to. In the previous chapter we conducted CFD simulations at
5, 10, 15, 20 and 25 ml/min to elucidate the relationship between volumetric flow rates, shear
stress and mass/oxygen transport in our cell seeded scaffold/reactor complex. In this chapter
we looked to empirically evaluate how these flow rates from the CFD simulations, with direct
oxygenation, effected cell morphology (i.e. aggregation), viability and metabolic output. The
overarching goal was to find the optimum flow rate that produced the best biochemical and
morphological outcome. Furthermore we sought to validate the CFD model as a future tool
that could be used as the building block for understanding how more complex oxygen
transport/delivery systems, nutrient uptake and flow could work within our perfusion
reactor/scaffold complex.
5.2 MATERIALS AND METHODS
5.2.1 Sources of Materials and Reagents
Medium molecular weight chitosan and glacial acetic acid were purchased from Sigma
Aldrich (St. Louis, MO).
5.2.2 Scaffold Fabrication
Scaffold fabrication technique, scaffold dimensions and materials used in making the
scaffolds for the experiments conducted in this chapter are consistent with those used in
chapter 3.
5.2.3 Hepatocyte Isolation
The technique, type of rats and reagents used to isolate and purify the hepatocytes
used in these experiments were consistent with those from chapter 3. Briefly, the hepatocytes
were isolated from Fisher rats by a modified two-step collagenase perfusion technique.
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5.2.4 Culture Conditions
The medium makeup (i.e. components and concentrations) and seeding protocol used
for the experiments conducted in this chapter were similar to those used in chapter 3.
However in this chapter all cultures were maintained in an atmosphere of 90% air/10% CO2
which preserved the pH at ~7.2. This pH is more consistent with the physiological acidity of
the liver and intracellular pH of its hepatic constituents.
Albumin protein synthesis and ureagenesis assays were performed to assess efficacy
of the bioreactor studies. The volume of medium in the bioreactor system and concentration
of cells seeded in each scaffold were factored into both calculations. Similar to chapter 3 two
double layer collagen sandwich culture systems were run in parallel with each bioreactor and
utilized as controls. The protocols for cell concentration, volume of medium used and top
collagen layer integration were consistent with those used in chapter 3.
The medium was extracted and replenished daily for both culture systems.

All

samples were stored at 4°C until analysis were perf ormed. Hepatocyte morphology and
viability were ascertained by histology using Hematoxylin and Eosin Y staining.

All

experiments in this chapter and going forward were conducted with the third generation
perfusion bioreactor system and flow circuit (Figure 35).
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Figure 35: Schematic of complete third generation perfusion culture circuit with expanded,
detailed schematic of the bioreactor chamber. The bioreactor image shows the fluid path
from inlet to outlet, oxygenation tubing and orientation of trapped hepatocytes
5.2.5 Metabolic Output Measurements
Enzyme Linked Immunoassay (ELISA) for Albumin
The protocol, reagents and instrumentation used to perform the ELISA assays for
these experiments were consistent to those from chapter 3.
Urea Assay
The protocol, reagents and instrumentation used to perform the urea colorimetric
assays for these experiments were consistent to those from chapter 3.
5.2.6 Histological Analysis
The protocol, reagents and instrumentation used to perform the histological analysis
for these experiments were consistent to those from chapter 3.
5.2.7 Statistical Analysis
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The biochemical functional output of the hepatocytes were calculated from duplicate
runs. The rates per day were averaged across duplicate runs and values are reported as
mean ± standard deviation.
5.3

Results

5.3.1 Effects of Direct Oxygenation (Static Bioreactor Culture)
The goal of this experiment was to evaluate the effects that direct oxygenation, without
the assistance of convective transport via media perfusion, has on the biochemical
functionality and morphology of the hepatocytes in this culture system. In both experiments
the scaffolds were seeded with an average of 101 million hepatocytes and cultured for a
duration of 7 days. The scaffolds were seeded at a flow rate of 20 ml/min until the desired
cell number per scaffold was achieved. In both cases the cell seeding process did not exceed
15 minutes.
In general, the culture did remain functional throughout the duration of the 7 day
period. As seen in Figure 36, protein synthesis, although very depressed and flat, was
measureable on every day. The highest rate of synthesis was noted on day 1, with an
average value of 0.727 µg/million cells/day. Surprisingly this was the only day that the
hepatocytes in both cultures experienced any convective oxygen transport, which occurred
exclusively during the 15 minute seeding process. A precipitous drop in protein synthesis
was seen from day 1 to day 2. However levels from day 2 to 7 exhibited slight fluctuations.
The mean urea synthesis for each day can be seen in Figure 37. Similar to albumin
protein synthesis, ureagenesis was highest on the first day with a value of 0.534 µg/million
cells/day. Based on evidence presented earlier it is no coincidence that the highest rate of
production was seen on the day that the cells were exposed to flow, albeit for a very short
time frame. The rate of production saw slight downshifts as the culture progressed. The sixth
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day of the culture saw the greatest difference in urea output of 98.9% between the static
reactor system and the control.
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Figure. 36: Rate of albumin synthesis produced by hepatoctyes cultured with direct
oxygenation and no perfusion vs. double layer collagen gel control. Error bars represent
standard deviation of 2 repeated measurements.
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Figure. 37: Rate of Ureagenesis produced by hepatocytes cultured with direct oxygenation
and no perfusion vs. double layer collagen gel control. Error bars represent standard
deviation of 2 repeated measurements.
Figure 38 shows a segment of the scaffold cross section between two direct
oxygenation tubes. It’s quite evident that all viable hepatocytes were clustered in close
proximity to the only oxygen source in the culture. Hepatic aggregation was nonexistent in
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the area between the oxygen tubes or at the scaffold periphery. Given that aggregation is
essential to cell viability it is assumed that all single hepatocytes died of necrotic factors
caused by lack of essential nutrients provided by convective transport. Viable cells within
each cluster were mostly seen at the edges of the aggregates indicating that hepatocytes
within the interior were deprived of oxygen (Figure 39 A to C). In addition to access to oxygen,
hepatocytes at the aggregate periphery probably remained viable because shear was not a
factor. A lesser number of small aggregates were seen slightly downstream of the oxygen
source. It is plausible that these cells remained functional only because: 1) they were able to
cluster during the seeding process; and 2) they were able to take advantage of the nutrient
containing medium not consumed by the large number of non-viable single cells. Lastly,
because hepatocytes can be motile in culture it can be deduced that the minimal level of
aggregation that occurred away from the oxygenation tubing, post seeding, was attributed to
these cells utilizing oxygen not consumed by the non-viable population to remain functional
and form multi-cellular masses.
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Figure 38: Histological montage (H&E stain) of static bioreactor culture (only direct
oxygenation). Arrows are pointing to embedded semi gas permeable tubing for direct
oxygenation. A is positioned in the central port inlet.
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Figure 39: Enlarged images of high oxygenated sections within scaffold from static bioreactor
culture (only direct oxygenation). A) arrow is pointing to area where gas permeable
oxygenation tubing was embedded. B) arrow is pointing to area where gas permeable
oxygenation tubing was embedded. C) Arrow is pointing in the direction of flow from the
scaffold central point inlet.
5.3.2 Effects of Direct Oxygenation and Convective Transport at 5 ml/min
The goal of this experiment was to evaluate the effects that direct oxygenation, with
convective transport facilitated by perfusion at 5ml/min has on liver-specific functionality,
viability and morphology. The scaffolds used in both experiments were seeded with 100
million and 105 million hepatocytes, respectively and cultured for a duration of 7 days. The
scaffolds were seeded at a flow rate of 20ml/min until the desired cell number per scaffold
was achieved. In both cases the cell seeding process did not exceed 15 minutes. Cells were
seeded in a 90% air/10% CO2 atmosphere. After the seeding process the flow rate was
quickly switched to 5ml/min for the duration of the seven day culture.
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Albumin synthesis, in general, was maintained over the 7 day period of the culture
with average peak levels reaching 12.894 µg/million cells/day on the first day (Figure 40).
Similar to the static culture, rates of production, in this condition, dropped significantly going
into the second day (~4 fold decrease). However from the second day to the cessation of the
culture, protein synthesis remained constant at an average of 3.5 ± 0.59 µg/million cells/day,
with the lowest rates seen on day 5 (2.66 µg/million cells/day).

When compared to the

control, the experimental culture yielded 41.6% more albumin on the first day. Day 2 was the
point where the control surpassed the experimental culture. At the conclusion of the culture,
the control was producing 95% more albumin than the perfusion condition.
Urea secretion results (Figure 41) show that hepatocytes cultured in perfusion had
lower function compared to the control.

Unlike albumin, urea secretion was consistent

throughout the culture with only minor fluctuations in rates between 24 hour periods. However
it should be noted that expression, albeit slightly, did decline as the culture progressed. The
maximum and lowest synthesis were seen on day 1 and 7, with values of 5.46 and 3.14
µg/million cells/day respectively. This represented less than a two-fold change. When both
days are juxtaposed to the control a 1.7–fold and 7.1–fold difference in levels were observed.
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Figure. 40: Rate of albumin synthesis produced by hepatoctyes cultured with direct
oxygenation and 5 ml/min perfusion vs. double layer collagen gel control. Error bars
represent standard deviation of 2 repeated measurements.
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Figure. 41: Rate of urea produced by hepatoctyes cultured with direct oxygenation and 5
ml/min perfusion vs. double layer collagen gel control. Error bars represent standard
deviation of 2 repeated measurements.
Figure 42 is a reconstructed montage that represents a one-eighth segment of the
scaffold cross-section. The overwhelming majority of hepatocytes within the section are not
aggregated, which based on hepatic physiology would clearly suggest that they are nonviable. Cell aggregation was evident and concentrated between the embedded oxygen
tubing, but not in close proximity to the tubing. There was insignificant spheroid formation
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and cell viability towards the periphery of the scaffold. Unlike the static culture, in this
condition, aggregation was not prevalent around the fluid inlet which, like areas adjacent to
the tubing, is considered a region of high oxygen tension. The fact that little to no viable cell
spheroids are visible around the oxygen tubing is counter to data presented in previous
sections. Because the aggregation process in perfusion scaffold cultures is usually flow
mediated it’s very plausible that this is simply due to the poor flow distribution which is
characteristic at low flow rates such as this one. Of the cells that did aggregate, they took on
more of an elliptical geometry that was in-line with the direction of the fluid trajectory. Figure
43 A, B and C show that viable cells were interspersed throughout the body of smaller
spheroids.

However for larger spheroids in the same images viable cells were more

concentrated at the periphery which would suggest that cells positioned towards the interior
succumbed to death via oxygen and nutrient deprivation.
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Figure 42: Histological montage (H&E stain) of 5 ml/min bioreactor culture with direct and
convective oxygenation. Arrows are pointing to areas where direct oxygenation tubing was
present during the culture. A is positioned in the central port inlet.
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Figure 43: Enlarged images of high oxygenated sections within the scaffold from 5ml/min
perfusion culture. Images A) and C) arrow are pointing to area where semi-permeable
oxygenation tubing was embedded. B) Arrow is in central port area and pointing in the
direction of the fluid path. D) Spheroids in mid-section of scaffold towards scaffold perimeter
5.3.3 Effects of Direct Oxygenation and Convective Transport at 15 ml/min
In this experiment, the volumetric flow rate of 15 ml/min was utilized to ascertain how
it affected mass transport within the scaffold micro-environment and its causal effect on
cellular respiration, viability and geometry.

The scaffolds used in both experiments were

seeded with 95 million and 100 million hepatocytes, respectively and cultured for a duration
of 7 days. The scaffolds were seeded at a flow rate of 20 ml/min until the desired cell number
per scaffold was achieved or if the number of entrapped cells did not significantly change over
time. In both cases the cell seeding process did not exceed 15 minutes. Cells were seeded
in a 90% air/10% CO2 atmosphere. After the seeding process the flow rate was quickly
switched to 15 ml/min for the remaining timeframe of the culture. It should be noted that the
histology stains for the montage and single aggregate images were taken from two different
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15 ml/min cultures. The individual stills that were used to construct the montage did not
provide the resolution needed to differentiate between viable and non-viable cells as
presented by haematoxylin nucleic acid staining.
Protein albumin synthesis shown in Figure 44, was maintained at a much higher rate
per day than pervious cultures. The topmost rate of synthesis was recorded on the second
day of the culture with a value of 28.615 µg/million cells/day. Protein production increased
from day 1 to day 2 by 54% but decreased by 61% from day 2 to day 3. However production
did, largely, remain constant until the last day where production abruptly plummeted by 72%.
When compared to the control, the experimental culture bested it by 48% and 46% on day 1
and 2 respectively. It was not until the third day that synthesis in the control exceed that of
the experimental condition. Furthermore, when evaluated using a paired t-test (p > 0.05),
there was no significant difference in protein synthesis up to day 6. Significance was exhibited
when the last day, from both groups, was factored into the analysis, which saw a 96%
difference in secretion (4.68 vs. 114.01 µg/million cells/day).
Figure 45 shows urea secretion rates over the duration of the seven day culture. The
highest point of ureagenesis was on day 1 with a value of 13.406 µg/million cells/day.
Ureagenesis remained in the double digits for more than half the length of the experiment.
Values dipped into single digit level on day 5 with a rate of 8.22 µg/million cells/day, which
was a -29% change from the previous day. Similar to albumin, urea production reached its
lowest level on the last day of the culture at 3.52 µg/million cells/day, which was a 51% drop
from the previous day. When compared to the control the experimental condition outpaced
it for the first two days with percent differences of 35% and 31% respectively. On the last day
of the culture, which was the worst showing for the reactor but the best for the control, there
was a production difference of 13.4 µg/million cells/day which translated to a 79% difference.
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When evaluated using a paired t-test (p > 0.05), there was no significant difference in
ureagenesis between both groups.
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Figure. 44: Rate of albumin synthesis produced by hepatoctyes cultured at 15 ml/min vs.
double layer collagen gel control. Error bars represent standard deviation of 2 repeated
measurements.
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Figure. 45: Rate of Ureagenesis produced by hepatocytes cultured at 15 ml/min vs. double
layer collagen gel control. Error bars represent standard deviation of 2 repeated
measurements.
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Figure 46 is a montage cross section that represents a segment of the scaffold. The
majority of hepatocytes within the section are in aggregate form. Unlike previous cultures
hepatocyte aggregation is very evident in all regions of the scaffold. However most of the cell
masses are concentrated around the central port and, adjacent or in very close proximity to
the oxygen tubing. Both of which are considered high oxygen tension regions of the scaffold.
The size of the hepatocyte clusters appear to be larger in these areas and decreased in size
downstream of the oxygen tubing. In addition to size, the geometry of each cluster, towards
the inlet, appeared to be more irregular. The aggregates tend to be more ellipsoidal as they
transition past the tubing to the scaffold periphery. Figure 47 A, B, C and D show that viability,
as detected by visible nuclear staining, is well dispersed throughout the aggregate interior
which would suggest that these cells were not deprived of oxygen and/or essential nutrients.
This makes sense as these cells are located in high oxygen tension area.

However

aggregates in images 47 E and F, which are located towards the scaffold perimeter, also
display comparable cell viability indicating good mass transport from inlet to outlet.

116

Figure 46: Histological montage (H&E stain) of scaffold cross-section from 15 ml/min
bioreactor culture with direct and convective oxygenation. Arrows are pointing to embedded
semi gas permeable tubing for direct oxygenation. A is positioned in the central port inlet.
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Figure 47: Enlarged images of cell aggregates from 15 ml/min flow rate bioreactor culture.
A and B are aggregates located adjacent to the oxygen tubing. C and D are located in close
proximity to the central port fluid inlet. E and F are positioned near the scaffold perimeter.
5.3.4 Effects of Direct Oxygenation and Convective Transport at 20 ml/min
The main objective of this trial was to observe how the perfusion rate of 20 ml/min
impacts oxygen and nutrient transport, and hydrodynamic forces, which influences hepatic
phenotypic behavior, morphology and death. The scaffolds used in both experiments were
both seeded with 100 million hepatocytes and cultured for a duration of 7 days. The scaffolds
were seeded and cultured at a flow rate of 20ml/min. In both cases the cell seeding process
did not exceed 15 minutes.

Cells were seeded and cultured in a 90% air/10% CO2

atmosphere. It should be noted that cultures at 20 and 25 ml/min were run simultaneously

118
from the same batch of isolated cells, and replicated with another isolated batch of cells on a
different day.
The production of albumin per day is presented in Figure 48. Protein, in general, was
secreted at very depressed levels each day of the experiment. The hepatocytes generated
the most albumin (6.67 ug/million cells/day) on the first day of the experiment. On the second
day of the culture expression rates decreased by 40%%. However levels seemed to stabilize
at 4.2 ± .13 µg/million cells/day, with very little fluctuation over the next 3 days before dropping
by 38% on day 5. It should be noted that production from day 5 to 7 also remained steady at
an average of 2.5 ± 0.33 µg/million cells/day and a mean percent change of 19%.

When

compared to the control the experimental group secreted much less protein. The gap in
synthesis continued to widen as the culture advanced. At the conclusion of the culture the
control generated 100 µg (98%) more than the experimental group.
Figure 49 illustrates the amount of urea produced per day over the seven day culture
period. Hepatocyte secretion was maximum on day 1 (4.8 µg/million cells/day) with very little
variation over the first six days of the experimental period.

The highest positive and lowest

negative change was seen from day 1 to 2 (+∆1.2 µg) and day 6 to 7 (-∆ 2.2 µg), respectively.
Production was lowest on the last day of the culture with a value of 1.97 µg/million cells/day,
which also showed greatest day-to-day slide of 52%. Contrasted to the experimental group,
the control continuously generated more urea per day except for day 2. When averaged,
there was little difference in the amount of urea produced on the first two days (4.2 µg –
bioreactor vs. 4.5 µg – control). However on day 7 the gap in production was substantial at
16 µg/million cells/day or 89%.
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Figure 48: Rate of albumin synthesis produced by hepatoctyes cultured at 20 ml/min vs.
double layer collagen gel control. Secretions rates for control were significantly higher when
compared to perfusion bioreactor model. Error bars represent standard deviation of 2
repeated measurements.
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Figure 49: Rate of Ureagenesis produced by hepatocytes cultured at 20 ml/min vs. double
layer collagen gel control. Secretion rates for control significantly outpaced those exhibited
by the perfusion culture.
Error bars represent standard deviation of 2 repeated
measurements.
Figure 50 is a reconstructed montage cross section of the hepatocyte seeded and
cultured scaffold at 20 ml/min. Under these conditions the cells were able to aggregate over
the seven day period. Unlike the previous condition it seems that the distribution of the
aggregates is more diffuse in nature which could be a function of the increased flow rate
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pushing or repositioning cells within the micro-environment. This could also explain why more
aggregates, in comparison to the previous condition, are noticeable towards the fluid outlet
regions of the scaffold and not in the high flow rate fluid inlet area. Another explanation could
be that high shear forces at the inlet caused cells to die thereby disrupting the aggregation
process. However it is obvious that the bulk aggregate population is positioned between the
oxygen tubing and not contiguous to the tubing. This is logical as this area has the greatest
pore interconnectivity and is in the fluid path of least resistance from inlet to outlet. Because
shear stress may be higher directly adjacent to the tubing, fluid displacement and a reduced
flow area could also account for the high concentration of aggregates between the oxygen
tubing.
In general the aggregates all look as if to have taken on the same shape, albeit varying
in size. Figures 51 A, B, C and D indicate that the clusters contain a mixture of viable and
dead hepatocytes. Although intact nucleic acid is present, when taking the biochemical
output into account, it is clear that the viable cells are not functioning at full capacity. This
could be due to shear stress imposed on the cells from the higher inlet flow rate.
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Figure 50: Histological montage (H&E stain) of 20 ml/min bioreactor culture with direct and
convective oxygenation. Arrows are pointing to embedded semi gas permeable tubing for
direct oxygenation. A is positioned in the central port inlet.
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Figure 51: Enlarged images of aggregates cultured at 20 ml/min. A) arrow is pointing to area
where semi-permeable oxygenation tubing was embedded. B) aggregates in area between
oxygenation tubing. C) aggregates towards the scaffold border. D) aggregates adjacent to
the central port fluid inlet.
5.3.5 Effects of Direct Oxygenation and Convective Transport at 25 ml/min
The main objective of this effort was to discern what impact, if any, does the flow rate
of 25 ml/min have on hepatocyte functionality, spheroid formation and shape, and death. In
this round of experiments scaffolds, in both trials, were seeded with 100 million hepatocytes
and cultured for a duration of 7 days. The scaffolds were seeded at a flow rate of 20 ml/min
until the desired number of cells were entrapped. The flow rate was subsequently switched
to 25 ml/min for the duration of the culture period. In both cases the cell seeding process did
not exceed 15 minutes. Cells were seeded and cultured in a 90% air/10% CO2 atmosphere.
It should be noted that cultures at 20 and 25 ml/min were run simultaneously from the same
batch of isolated cells, and replicated with another isolated batch of cells on a different day.
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The rate of albumin generated per day is presented in Figure 52. From the onset of
the culture it was obvious that cell functionality was compromised.

Protein expression

reached its pinnacle on the first two days of culture with an average value of 4.43 ± 0.16
µg/million cells/day. Subsequent to this point synthesis fell sharply and output decreased
47% by day 3. Although there was a slight increase in production on day 4 and 5, by the end
of the experiment, albumin secretion plummeted to 1.49 µg/million cells/day which equated
to a 66% drop from the highest levels seen on day 1 and 2. When the results from the control
group were compared to the experimental study, it’s very obvious that the control group
generated considerably more albumin on a per day basis. The gap in synthesis continued to
widen as the culture advanced. At the conclusion of the culture the control generated 99%
more protein than the experimental group.
Figure 53 shows the comparative rates of urea excretion by hepatocytes in the
perfusion and control groups throughout the seven day study. Urea secretion from beginning
to end was paltry. Rates on day 1 and 2 were relatively flat but increased 31% to reach its
maximum value of 4.26 µg/million cells/day by day 3.

Urea dropped by 17% by day 4 and

remained rather constant (± .30) for the rest of the culture. Contrasted to the experimental
group, the control performed much better per day. By the conclusion of the culture, the
bioreactor culture was producing 15 µg/million cells/day or 62% less urea than the control
group.
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Figure 52: Rate of albumin synthesis produced by hepatoctyes cultured at 25 ml/min vs.
double layer collagen gel control. Error bars represent standard deviation of 2 repeated
measurements.
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Figure 53: Rate of Ureagenesis produced by hepatocytes cultured at 25 ml/min vs. double
layer collagen gel control. Error bars represent standard deviation of 2 repeated
measurements.
Figure 54 is mosaic cross section of the hepatocyte embedded scaffold that was
seeded and cultured at 25 ml/min. The overwhelming majority of hepatocytes were not able
to form multi-cellular masses in this experimental setting. However spheroid formation is very
noticeable in certain areas. Under the perfusion rate of 20 ml/min cell aggregation was mainly
confined to the section between the oxygenation tubing as this was the assumed region
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where the fluid trajectory was unburdened by the tubing. This image does deviate from this
notion in that clustering is more prevalent around the inlet and adjacent to the oxygen tubing.
It is also conceivable that the increased flow rate adversely affected the cell’s ability to
aggregate by adhesion molecule (E-cadherin or Integrin alpha 1) disruption.

Although

spheroid formation was negligible in the central body of the scaffold, the cells ability to interact
seems to heighten towards the construct’s border. This intensity of cell-to-cell interaction, at
the margins, was not noticed in previous experiments. The shear stress in this area probably
did not exceed the threshold for cell damage which permitted cells to aggregate and remain
functional.
Of the hepatocytes that were able to form larger cell masses, the viability profile shown
in Figure 55, in general, is very comparable to the previous cultures as these cells were
randomly positioned and more than likely functioning at diminished capacities.

In some

masses it was observed that viable cells seem to be positioned one to two cell layers inward
from the boundary. More than likely the cells at the aggregate border apoptosed due to the
hydrodynamic force imposed on them. Regarding morphology, the aggregates in the front
third of the scaffold, appear to be analogous to each other. The smaller cell clusters at the
fluid egress also share the same shape.
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Figure 54: Histological montage (H&E stain) of hepatocyte seeded scaffold cultured at 25
ml/mi. Arrows are pointing to embedded semi gas permeable tubing for direct oxygenation.
A is positioned in the central port inlet.
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Figure 55: Enlarged images of aggregates cultured at 25 ml/min. A & C) arrows are pointing
to areas where semi-permeable oxygenation tubing was embedded.
B) hepatocyte
spheroids adjacent to central port inlet. D) hepatocyte aggregates at scaffold border.
In addition to measuring against a control, results from all six experimental conditions
were plotted together and compared versus each day in culture. Figures 56 and 57, show
the compared results for albumin synthesis and ureagenesis versus each day in culture.
When compared, the experimental condition of 15 ml/min, over the seven day timeframe,
induced better albumin and urea secretion rates. Day 1 and day 2 expressed the best results
for urea and albumin respectively. For both functional metrics 10 ml/min induced the second
highest production rates followed by 5ml/min. On the day of peak functionality, albumin
secretion at 15ml/min outpaced production at 10 ml/min by 68% and 87% under 5 ml/min.
The contrast was not as stark for ureagenesis. The percent difference on day 1 between 15
and 10 ml/min was 24% and 59% between 15 and 5 ml/min. From both graphs it is evident
that there is a causal relation between mass transport and flow rate. As the flow rate
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increased from static to 15 ml/min so did the efficacy of mass transfer which is supported by
higher protein and urea output.

However because hepatocytes are shear averse the

assumption that increased fluid velocity translates to better mass transport efficiency ergo
enhanced liver-specific functionality is not sustainable. The inflection point where fluid flow
became detrimental to hepatocyte phenotypic expression, most likely due to shear stress,
was at 20 ml/min. At this rate and higher, biochemical yield was in general lower than the
other dynamic cultures. Lastly, Figure 58 also shows somewhat of a relationship between
flow rate and aggregate area.

This relationship, to a lesser degree, does extend to the

number of cell aggregates. When the montage images for all experimental conditions are
equated it can be suggested that as flow rates increase, more cells masses are present.
Though the appearance of more aggregates does seem to subside at 25 ml/min.
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Figure 56: Albumin synthesis rates from each culture condition compared over the seven day
culture period.
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Figure 57: Ureagenesis rates from each culture condition compared over the seven day
culture period.
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Flow Rate vs. Aggregate Area
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Figure 58: Flow rate culture conditions vs. hepatocyte aggregate area. Chart shows
correlation between flow rate and hepatocyte area. Phase contrast microscopy images from
replicates under each culture condition were used to generate area calculations.
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Table 5: paired t-test (equal variance) results that establish significance or insignificance
between the effects of varying flow rates on albumin protein synthesis. Plus (+) denotes that
there was a significant difference between the two populations. Minus (-) sign denotes that
there was no significant difference between the two sample populations.
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Static

Static

5ml/min

10ml/min

15ml/min

20ml/min

25ml/min

N/A

+

+

+

+

+

+

+

-

-

-

+

+

+

+

5ml/min

+

N/A

10ml/min

+

+

15ml/min

+

+

-

20ml/min

+

-

+

+

25ml/min

+

-

+

+

N/A
N/A

N/A

-

N/A

Table 6: paired t-test (equal variance) results that establish significance or insignificance
between the effects of varying flow rates on urea secretion. Plus (+) denotes that there was
a significant difference between the two populations. Minus (-) sign denotes that there was
no significant difference between the two sample populations.
A paired t-test (equal variance, p>.05) was performed on all samples from each
experimental trial.

From Table 5 the amount of albumin generated at 15 ml/min was

statistically significant from every other group. The same can be said for urea except when
compared to 10 ml/min where there was no statistical significance (Table 6). There was also
no statistical significance between the 10 and 5 ml/min groups for albumin synthesis.
Surprisingly there was no statistical difference between the data generated at 5 ml/min and,
20 ml/min and 25 ml/min for urea and albumin. This demonstrates how low flow (inefficient
mass transfer) and excessive flow (damaging shear forces) can influence similar functional
outcomes.
5.4

Discussion
Previous studies in this body of work demonstrated the iterative optimization of the

current bioreactor perfusion system and the computational fluid dynamic simulations used to
optimize inlet mass flow rates based on the oxygen uptake kinetics and hydrodynamic stress
profiles with the scaffold micro-environment. In this study the flow rates utilized in the CFD
simulations from the previous chapter were empirically evaluated to understand how shear
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stress and mass transfer, via increased flow rates, affect cell morphology and spheroid
formation, and liver-specific hepatocyte function with the scaffold micro-environment.
Dynamic cultures, regardless of the cell type, species, or dimension of the system (2D
or 3D) tend to outperform their static counterparts. Every bioreactor culture condition in this
study, irrespective of inlet flow rate, was continuously bested by its static control. However
when these conditions are equated inter-experimentally, increased fluid flow, to a certain
magnitude, did translate to better metabolic performance and, enhanced aggregate formation
and area. This is likely due to better mass transport of oxygen and essential nutrients to
hepatocytes, and the continuous removal of waste bi-products from the system. Moreover a
similar perfusion study pointed out that increased fluid velocity, to a certain degree, produced
a larger biochemical response (vs. static) because mechanical stress prompted the
polymerization of actin fibers within the hepatic cytoskeleton, and subsequent cell aggregateto-scaffold adherence [253]. These finding do suggest that within this experimental setup
mechanical stress and mass transfer, both of which are facilitated by perfusion, do play a
roles in fostering a micro-environment that is more conducive to spontaneous spheroid
formation and enhanced cellular vitality.

All of which are consistent with other hepatic

perfusion bioreactor studies.
As the flow rate increased from static up to 15 ml/min there was a marketed surge in
the number and area of hepatocyte clusters. The previous paragraph gave insight as why
this happen mechanically. However from a gene expression perspective Hughes-Fulford and
Chang [254] found that a number of beneficial genes are activated by intense cell-to-cell
interactions. Hnf4a (aka Nr2a1), a liver-enriched transcription factor known to be essential
in maintaining mature differentiated liver function, was significantly upregulated in hepatic 3D
aggregate cultures. In fact, of the genes activated due to hepatocyte aggregation more than
50% contained HnF4a binding sites.

It concluded that aggregation is necessary for

133
maintaining Hnf4a expression and that it is a major transcriptional effector or master regulator
of physiological hepatocyte function and phenotype.
The flow rate at which the benefits of efficient mass transport, facilitated through
increase fluid flow, exceeded the threshold for compromised cell function, possibly through
heightened shear stress, was observed at 20 ml/min. As experiments transitioned to higher
flow rates (20 and 25 ml/min) it was quite evident that the hepatocyte’s ability, over the
duration of the culture, to establish cell-to-cell diminished. The lack of these interactions for
anchorage dependent cells leads to depressed metabolic activity. The first mechanism that
induces this form of cell death occurs when E-cadherin expression is perturbed or absent. Ecadherins are Ca2+-dependent, cell-to-cell adhesion molecules that that have been implicated
as a sources of cell death in epithelial cells when abrogated [255]. A study conducted by
Nyberg et al. showed that E-cadherin inhibition produced maximal cell death, induced
heightened levels of DNA fragmentation and suppressed spheroid formation. The study also
concluded E-cadherins are responsible for protecting hepatocytes from caspase-independent
apoptosis. Another study involving Nyberg showed that E-cadherins are present along the
basolateral membrane between rat hepatocyte spheroids and their reduced interactions on
the hepatic surface maybe responsible for increased cell loss [256]. These results lend more
credence to the results presented in this study as the final hepatocyte orientation, post
seeding, is random.
β-1 integrins are part of a family of adhesion molecules that contain numerous cell
receptors that help govern cell-to-ECM interactions and trigger cell-survival signaling
cascades during cell–ECM contact. It has been shown in epithelial cell cultures that caspases
are activated during apoptosis in the absence of β1-integrin mediated signaling events [257].
From a histological examination it is evident that hepatocytes, in this study, are in contact with
their ECM environment which would suggest that the upregulation of β-1 integrin expression
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via cell-to-ECM interaction occurred or was feasible. However high shear forces imposed on
the cells at the 20 and 25 ml/min conditions most like caused the cells to die either before or
after the hepatocytes were able to establish contact with chitosan/collagen ECM. If cell death
occurred after ECM attachment this could suggest that the death mechanisms caused by
shear stress take precedence over those that lead to cell survival through β-1 integrin
expression.
It is necessary to also mention how the direct application of shear stress up-regulates
the expression of certain genes and proteins that can mediate cell death through proapoptotic pathways. Plasminogen activator inhibitor 1 (PAI-1) is involved in a number of
biological processes such as cell migration, angiogenesis and ECM degradation. It was
demonstrated that hepatocytes, when exposed to shear stresses up to 40 dyne/cm2,
exhibited marketed increases in PAI-1 mRNA expression and PAI-1 protein release through
the cooperative interactions between the transcription factors Sp1 and Ets-1 [258]. ECM
accumulation is the hallmark of hepatic fibrosis. It has been shown that the overexpression
of PAI-1 induces ECM accumulation and mitochondria-mediated apoptosis through TGF-B1
molecular mediators - Smad3/4 and p38 [259] . Both observations taken together might
describe or provide an alternate explanation as to how excessive hydrodynamic forces, either
debilitate hepatic functionality or encourage apoptotic cell death.
5.5

Conclusion and Future Work
The hepatocyte’s ability to synthesize albumin protein and modify ammonia into urea

are two major hallmarks of in-vivo function. Both of which were used to gauge the overall
performance of this system. The results introduced in this chapter demonstrated that isolated
primary hepatocytes can re-aggregate under mechanical stress and maintain cell vitality for
the duration of the designated culture period. The data presented in this body of work also
reveals how shear stress and mass transfer, both functions of fluid flow within the scaffold
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micro-environment, can be tuned to foster optimum cellular output within this system.
Because of the work conducted in this chapter and the understanding of oxygen uptake
kinetics provided in the previous chapter, the flow rate 15ml/min at the central port inlet will
be used for the remaining bioreactor experiments.
Efficient mass transfer of oxygen and essential nutrients, and the cell’s ability to
spontaneously aggregate are two major factors that influence the maintenance of mature
hepatocyte differentiation. Thus improving both aspects would lend to the performance and
viability of the scaffold-bioreactor complex utilized in this study. In the following chapter
scaffold dimensions are reduced to determine if decreasing the cell number-to-scaffold void
volume ratio can promote better metabolic activity. It is hypothesized that by doing this
hepatocyte spheroids will be closer in proximity to an oxygen source (i.e. oxygen tubing or
media), the time needed to aggregate will be mitigated while the number of aggregates will
increase and the mass transfer distance to cells masses located at the scaffold periphery will
be attenuated.
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CHAPTER SIX: EVALUATION OF HOW THE REDUCTION IN
SCAFFOLD DIMENSIONS AND INCREASED CELLULAR
COMPACTNESS INFLUENCE LIVER PHENOTYPIC EXPRESSION AND
AGGREGATE FORMATION
6.1 Introduction
Hepatocyte spheroid formation, in vitro, helps to mimic the in vivo morphology and
ultrastructure by reestablishing necessary intercellular communication channels.

The

beneficial role of spheroids in recapitulating in vivo-like polarity and, maintaining viability and
overall differentiated functionality has been well documented [260-262] especially when
compared to hepatocytes cultured as monolayers. One of the challenges for perfusion-based
seeding of single cell suspensions in bulk scaffolds is controlling the overall size and
dimensions of the eventual hepatocyte aggregates. To some degree this can be controlled
by the size and direction of the pore structure within the construct’s interior. However just as
important is creating a micro-environment that facilitates enhanced flow-mediated spheroid
formation of these single cells suspensions during the seeding process.
The holy grail of tissue engineering scaffolds is to generate a construct that can fully
integrate into and mimic the native tissue microenvironment, and facilitate fast functional
regeneration of the defected tissue space. Much effort has been spent on understanding the
how pore size [263-265], porosity [181, 265], scale of pore interconnectivity [266, 267]
influence graft integration, mechanical stability and overall functionality of the scaffold’s
cellular inhabitants. However reciprocal energies have not been given to ascertaining how
geometry, or more germane to this case, the geometrical size with increased cell density can
modulate native cellular responses. Rumpler et. al demonstrated how geometrical features
and scaffold size strongly influenced local growth rates of tissue formed by osteoblasts [268].
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Troken et. al. reported the positive effects, via von Kossa staining, that increased hMSCderived chondrogenic and osteogenic cells packing had on mineral deposition in in-vitro
cultures [269]. Similarly with hepatocytes, higher density seeded scaffolds tend to induce
more favorable cellular responses.

Dvir-Ginzberg et. al. [270] showed the positive

relationship between increased cell packing densities within alginate scaffolds and liver
specific functionality.

Essentially as hepatocyte densities increased viability, metabolic

functionality and P-450 activity not only increased but were maintained at high levels for the
duration of the culture periods. Furthermore in-vivo characteristics were more prominent with
increased cellular compactness.
In the previous chapter it was noticed that the overwhelming majority of cellular
clusters in the 15ml/min culture were localized between the central inlet-port and oxygen
tubing.

The aim of this chapter was to evaluate the effect that reducing the scaffold

diameter/thickness and the mass transfer distance (i.e from central inlet to scaffold perimeter)
has on cell aggregation, viability and overall functionality. The working hypothesis for this
experiment was that increasing the cell packing density by decreasing the scaffold volume
will increase the hepatocytes’ ability to form more multi-cellular clusters thereby facilitating
better cell-specific functionality byway of enhanced cell-to-cell and cell-to-ECM interactions.
Because heightened aggregation can pose mass transfer limitations [193, 271], minimizing
the gap between cells and, the main and adjunctive oxygen sources (central port inlet and
oxygenation tubing respectively), will help overcome these limitations and aid in supporting
hepatic respiration. Porous chitosan scaffolds at 14% and 30% of the original thickness were
generated, seeded with hepatocytes, cultured in perfusion for the duration of seven days and
assessed for their beneficial contribution to hepatocyte phenotypic expression.
6.2 Materials and Methods
6.2.1 Sources of Materials and Reagents
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Medium molecular weight chitosan and glacial acetic acid were purchased from Sigma
Aldrich (St. Louis, MO).
6.2.2 Scaffold Fabrication
Scaffold fabrication technique used in making the scaffolds for the experiments
conducted in this chapter are consistent with those used in previous chapters. The scaffold
diameters were decreased by 14% (1.29 cm) and 30% (1.05 cm). The height of the scaffold
remained constant at 2.5 cm (Figure 59).

Figure 59: Schematic of 14% and 30% reduced diameter chitosan scaffolds with Silicone
Tubing
6.2.3 Hepatocyte Isolation
The technique, type of rats and reagents used to isolate and purify the hepatocytes
used in these experiments were consistent with those from chapter 3. Briefly, the hepatocytes
were isolated from Fisher rats by a modified two-step collagenase perfusion technique.
6.2.4 Culture Conditions
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The medium makeup (i.e components and concentrations) used for the experiments
conducted in this chapter were similar to those used in chapter 3. However in this chapter
hepatocytes were seeded and culture with a flow rate of 15 ml/min. All cultures were
maintained in an atmosphere of 90% air/10% CO2 which preserved the pH at ~7.2.
Albumin protein synthesis and ureagenesis assays were performed to assess efficacy
of the bioreactor studies. The volume of medium in the bioreactor system and concentration
of cells seeded in each scaffold were factored into both calculations. Similar to chapter 3 two
double layer collagen sandwich culture systems were run in parallel with each bioreactor and
utilized as controls. The protocols for cell concentration, volume of medium used and top
collagen layer integration were consistent with those used in chapter 3.
The medium was extracted and replenished daily for both culture systems.

All

samples were stored at 4°C until analysis were perf ormed. Hepatocyte morphology and
viability were ascertained by Hematoxylin and Eosin Y staining.
6.2.5 Metabolic Output Measurements
Enzyme Linked Immunoassay (ELISA) for Albumin
The protocol, reagents and instrumentation used to perform the ELISA assays for
these experiments were consistent to those from chapter 3.
Urea Assay
The protocol, reagents and instrumentation used to perform the urea colorimetric
assays for these experiments were consistent to those from chapter 3.
6.2.6 Histological Analysis
The protocol, reagents and instrumentation used to perform the histological analysis
for these experiments were consistent to those from chapter 3
6.2.7 Statistical Analysis
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The biochemical functional output of the hepatocytes were calculated from duplicate
runs. The rates per day were averaged across duplicate runs and values are reported as
mean ± standard deviation.
6.3

Results

6.3.1 Effects of 14% Reduction in Scaffold Diameter
The focus of this effort was to recognize what effect or impact that reducing the
scaffold’s diameter by 14% (1.29 cm) had on spheroid formation which subsequently
modulates hepato-cellular functionality and overall viability. In this round of experiments
scaffolds were seeded with 87.5 and 90 million hepatocytes and cultured for a duration of 7
days. Based on the shear stress data presented in the previous two chapters the scaffolds
were seeded at a flow rate of 15 ml/min for no more than 15 minutes. The time limit of 15
minutes was used in order to maintain continuity with previous experiments and to better
compare data from chapter 5. Cells were seeded and cultured in a 90% air/10% CO2
atmosphere. It should be noted that cultures with scaffold reductions of 14% and 30% were
run simultaneously from the same batch of isolated cells, and replicated with another batch
of isolated cells on a different day.
The rate of albumin secretion per day is exhibited in Figure 60.

Protein expression

under this culture condition reached its maximum level on day one with a value of 8.41
µg/million cells/day. From this point to on the secretion rates continued to drop with the final
output of 1.84 µg/million cells/day on day 7. This represented a 78% decrease in functionality
when compared to day one of the culture. When the results from the control group were
compared to the experimental study, it’s very obvious that it generated considerably more
albumin on a per day basis. However it should be noted that the experimental group did
outpace the control by .17 µg/million cells/day or 2% on day 1. From day 2 to 7 the margin

141
between the two groups increased and reached a peak difference of 112 µg/million cells/day
or 98% at the conclusion of the experiment.
Figure 61 shows the comparative rates of urea excretion by hepatocytes in the
perfusion and control groups throughout the seven day study. Similar to albumin, urea
secretion on the first day of the culture reached its maximum value (5.476 µg/million cells/day)
and exceeded that of the control group by .62mg/million cells/day or 11%. The amount of
ammonia conversion from day 2 to 4 was relatively flat in that only a 10% decrease in
phenotypic function was identified. Urea rates did exhibit downward shifts from day 5 forward
with the final value of 1.655 µg/million cells/day on day 7.

When contrasted to the

experimental group, the control performed much better per day, except on day 1. By the
conclusion of the culture, the bioreactor culture was producing 18.92 µg/million cells/day or
92% less urea than the control group.
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Figure 60: Rate of albumin synthesis produced by hepatoctyes cultured in scaffold with 14%
reduced diameter vs. double layer collagen gel control. Error bars represent standard
deviation of 2 repeated measurements.
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Figure 61: Rate of ureagenesis produced by hepatoctyes cultured in scaffold with 14%
reduced diameter vs. double layer collagen gel control. Error bars represent standard
deviation of 2 repeated measurements.
Figure 62 is a mosaic cross section of the hepatocyte seeded scaffold whose diameter
was decreased from 1.5 cm to 1.29 cm, constituting a 14% reduction. Based on the montage
it is clear that the majority of the pore space is occupied by hepatocytes. Spheroid formation
was minimal and confined to areas adjacent to the oxygen tubing and central port inlet. There
was also marginal aggregation in certain regions between the oxygenation tubing and by the
fringes of the construct. Of the hepatocytes that were able to aggregate their morphology
was very thin in width and lengthy, and did not resemble the irregular geometry of the previous
15 ml/min culture. The viability profile displayed in Figure 63 A, B, C and D showed that there
is minimal cells that survived the experimental culture period. Based on the metabolic data
in the aforementioned paragraphs it is evident that those that did survive were functioning in
a very depressed state.
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Figure 62: Histological montage (H&E stain) of hepatocyte seeded scaffold with a 14%
reduction in the diameter.
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Figure 63: Enlarged images of single cells and aggregates cultured in the scaffold with a
14% reduced diameter. A & B) displaying hepatocytes and clusters adjacent to oxygenation
tubes. C) hepatocytes and spheroids adjacent to central port inlet. D) hepatocytes and
aggregates at scaffold border.
6.3.2

Effects of 30% Reduction in Scaffold Diameter
In this experiment the diameter of the scaffold was reduced by 30% (height did not

change) to understand how decreasing the total mass transport distance (from central port to
outlet) and increasing cell density within the construct would affects cells’ ability to form multcellular aggregates, function and remain viable for the duration of the culture period.

The

scaffolds used in both experiments were seeded with 83 million and 81 million hepatocytes,
respectively and cultured for a duration of 7 days. The scaffolds were seeded at 15 ml/min
and maintained at this flow rate for the length of the culture. It should be noted that cultures
with scaffold reductions of 14% and 30% were run simultaneously from the same batch of
isolated cells, and replicated with another batch of cells isolated on a different day.
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Protein albumin synthesis shown in Figure 64, was maintained at a much higher rate
per day than all cultures presented in previous chapters. The topmost rate of synthesis was
recorded on the second day of the culture with a value of 32.63 µg/million cells/day. The
greatest increase in protein production (35%) was observed from day 1 to day 2. Secretion
rates, in general, remained constant until the last day where production dropped by 27% to
22.19 µg/million cells/day. When compared the control the experimental culture secreted
61% and 63% more protein on day 1 and 2 respectively. It was not until the third day that
synthesis in the control exceed that of the experimental condition. When evaluated using a
paired t-test (p > 0.05), there was no significant difference in protein synthesis between both
groups.
Figure 65 shows urea secretion rates over the duration of the seven day culture.
Overall ureagenesis was maintained for the duration of the culture although there was a
continuous decrease in rates as the culture progressed. However it should be noted that
levels, on a day-to-day basis, did remaining higher than any previous experimental culture
presented in this body of work. Days 1 and 2 both exhibited very similar rates of urea
production, 18.189 and 18.334 µg/million cells/day respectively, and were the highest points
of production for the span of the culture. Ureagenesis remained in the double digits for 5 out
of 7 days. Values dipped into single digit level on day 6 with a rate of 6.81 µg/million cells/day,
which was a -44% change from the previous day. The lowest level of 5.830 µg/million
cells/day was observed on the last day of the culture which only represented a -14% from the
previous day. When compared to the control the experimental condition outpaced it for the
first four days with percent differences of 73%, 68%, 19% and 12%. On the last day of the
culture, which was the worst showing for the reactor but the best for the control, there was a
production difference of 14.74 µg/million cells/day which translated to a 71% difference.
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When evaluated using a paired t-test (p > 0.05), there was no significant difference in
ureagenesis between both groups.
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Figure 64: Rate of albumin synthesis produced by hepatoctyes cultured in scaffold with 30%
reduced diameter vs. double layer collagen gel control. Error bars represent standard
deviation of 2 repeated measurements.
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Figure 65: Rate of ureagenesis produced by hepatoctyes cultured in scaffold with 30%
reduced diameter vs. double layer collagen gel control. Error bars represent standard
deviation of 2 repeated measurements.
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Figure 66 is a montage that represents a complete cross section of the scaffold
diameter. The majority of hepatocytes within the section are, for the most part, were able to
form and sustain multi-cellular masses. Hepatic aggregation is very pronounced in all regions
of the scaffold with great evidence of such in regions near the central port, oxygenation tubing,
midsections between the tubes and at the scaffold periphery. Because the majority of the
scaffold’s interior was either adjacent or in close proximity to the central port and gas
permeable tubing, the bulk of the construct can be classified as a high oxygen tension region.
The size of the hepatocyte aggregates, in general, appear to be larger in and around the
central port and decrease downstream of this area. However aggregates of comparable size
can be observed around the construct’s periphery (Figure 67 C). The geometry of the
aggregates in the midsections follows no distinct pattern although those near the oxygen
tubing tend to mold themselves to the contours of the impregnated tubing. Figure 67 A, B, C
and D show that viable cells are well dispersed throughout the aggregate interior which would
suggest that these cells were not deprived of oxygen and/or essential nutrients. It should be
noted that all viable cells, as detected by intact nucleic acid, are in aggregates. Viability
among single cell hepatocytes was not evident. Aggregates located at the scaffold perimeter
(Figure 67 D), also displayed viable cells which would indicate that these cells too were not
deprived of nutrients or appropriate oxygen tensions. However there are peripheral segments
of the scaffold where cell numbers are low or non-existent. It’s assumed that larger spheroids
before this area blocked fluid flow to these parts thus causing uneven flow distribution and
diminishing the chances for aggregation and survival.
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Figure 66: Histological montage (H&E stain) of hepatocyte seeded scaffold with a 30%
reduction in the diameter.
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Figure 67: Enlarged images of aggregates cultured in scaffold with 30% reduced diameter.
A & C) displaying hepatocyte clusters adjacent to semi-permeable oxygenation tubes. B)
hepatocyte spheroids adjacent to central port inlet. D) hepatocyte aggregates at scaffold
border.
To understand the scale of functionality from these experimental conditions the results
were plotted together with the best results from the previous chapter (flow rate of 15 ml/min)
and compared versus each day in culture. Figures 68 and 69, show the compared results for
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albumin synthesis and ureagenesis versus each day in culture. When compared, the scaffold
that had its diameter reduced by 30% had the greatest positive influence over hepatocytespecific function as it facilitated better albumin and urea production over the seven day culture
period. The 1.5 cm scaffold culture induced the second highest production rates followed by
the culture that had the 1.29 cm scaffold diameter. Peak albumin production by the 1.05 cm
scaffold culture was exhibited on day 2 which exceeded the other two conditions on their best
days of secretion by 12.3% (1.5 cm – day 2) and 74.2% (1.29 cm – day 1). As the cultures
progressed the gap in protein production widened even further. Because the decline in
secretion rates by the 30% reduced diameter culture was not as drastic, at day 7 there was
92% gap in production when compared to the 1.29 cm scaffold culture and 79% with the 1.5
cm scaffold culture. Regarding ammonia conversion all three conditions followed similar
trends in that rates were highest and consistent on day 1 and 2. However as the cultures
continued, declines in transformation were exhibited on a daily basis in all three conditions.
The percent difference on day 1 between the 1.05 cm and the 1.5 cm scaffolds was 26.2%,
and 70% between the 1.5 cm and 1.29 cm scaffolds. On day 6 the 1.05 cm and 1.5 cm
scaffold cultures demonstrated very similar ureagenesis rates as there was only a 6%
difference in favor of the latter. On day 7 the 1.5 cm scaffold had a sharper drop in production
than the 1.05 cm (51.2% vs. 14%), which overall represented a 40% difference in final
secretions rates. If the 1.29 cm scaffold is included the percent difference in urea production
is -53% when compared to the 1.5cm scaffold and -72% with the 1.05 cm scaffold. When
comparing biochemical production from the 1.5 cm and 1.05 cm scaffolds it can be concluded
empirically that, if the culture flow rate remains constant, distance and mass transport do
share an association. However based on functional performance and IHC scaffold cross
sections this conclusion cannot be applied to the 1.29 cm scaffold culture. However what
might explain the difference in aggregate formation, viability and general functionality is the
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flow rate during seeding. It is thought that the seeding flow rate of 15 ml/min in the scaffold
of 1.29 cm was not sufficient to induce the primary stages of aggregation. Essentially at the
scaffold diameter of 1.29 cm maybe 20 ml/min or more is initially needed to put the cells in
close enough proximity to each other so that the culture flow rate of 15 ml/min would suffice
to cause cell-to-cell contact. There is no conclusive data to support such a claim however it
does provide a framework that, with more analysis, could support the experimental
conclusions.
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Figure 68: Albumin synthesis rates from each culture condition compared over the seven day
culture period.
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Ureagenesis (Scaffold Size Comparison)
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Figure 69: Urea secretion rates from each culture condition compared over the seven day
culture period.
6.4

Discussion
For acellular or cell infused tissue engineered constructs one of the major

impediments is achieving medically relevant cell densities that leads to proper functional
integration into the damaged host tissue space. These densities facilitate the critical cell-tocell and cell-to-ECM interactions that aids in mimicking a physiological architecture and
intricacies of the native tissue. These interactions allow for biological functions such as
protein harboring and secretion [272] and the dynamic interplay of ions, metabolites and
reactive oxygen species [273] that modulate second messenger mediated signaling
cascades. Innate functionality stemming from this types of high density cell seeding, prior to
in vivo integration, is also challenged by mass transport limitations in vitro, and that spatial
distribution of the cellular constituents may lead to inconsistencies in metabolite, cytotoxic byproduct, and oxygen and nutrient gradients.
The main scope of this study was to increase the cell packing density of the scaffold
constructs, condense the cell-to-oxygen source distance and assess the concomitant effect
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that both have on metabolic functionality, morphology and viability.

The experimental

condition which decreased the scaffold diameter from 1.5 cm to 1.05 cm increased the cell
packing density by ~14% by reducing the scaffold volume by 30% but only reducing the
amount of seeded cells by 16%. The impact of this experimental condition clearly paid
dividends in that it promoted a markedly increase in protein production and ureagenesis when
compared to previous cultures. This increase in metabolic production was supported by
increased colonization and cell viability throughout scaffold interior. Variations in seeding
densities were used by Xu et al. [274] to examine their effects on hepato-specific function.
They determined that by increasing the cell density from 1 x 105/ml to 5 x 106/ml in BAL
reactors diazepam degradation, urea synthesis, incorporation of [3H]-leucine into protein, and
p53 gene expression were enhanced. Zhang et. al hypothesized that the level liver specific
functionality seen in their high density cultures were maintained by, but not limited to, tight
junction and desmosome formation by way of contiguous hepatocyte interaction [275].
Numerous viable cells were exhibited in multiple hepatocyte colonies.

In addition to

enhanced cell and extracellular matrix interactions brought about cell packing, it’s feasible to
correlate this level of viability and subsequent functionality to more efficient and effective
mass transfer. Although there is no empirical data to support this but it is suspected that
aggregate size hindered nutrient exchange thus causing the intermixed non-viable cells to
die of necrotic medicated factors. Necrosis could also explain why dead cells within these
multi-cellular masses are clustered together versus individually dispersed.

Saito et. al.

demonstrated that hepatocytes, when stimulated by an appropriate death cell (necrotic)
stimuli, will undergo necrosis but more importantly will transfer similar death signals, via gap
junction intracellular communication, to attached hepatocytes in a synchronic fashion [276].
Similar findings were also seen in glia cells that were susceptible to cell death via oxidative
stress, metabolic inhibition or calcium overload. These cells, when connected to less
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vulnerable cells through gap junctions, propagated and amplified the signals that induced cell
injury. The level of cell injury leading to death was in direct proportion to the number and
density of gap junctions formed with uncompromised cells [277].
The experimental condition which decreased the scaffold diameter from 1.5 cm to 1.29
cm increased the cell packing density by ~5% by reducing the scaffold volume by 14% but
only reducing the amount of seeded cells by 9%. The impact of this experimental condition
proved to be very detrimental to the culture’s viability and hepatocellular expression. Contrary
to the previous condition and the prevailing condition from chapter 5 (15 ml/min flow rate),
this culture exhibited insignificant levels of aggregation which is tantamount to cellular activity.
Because of this suppressed metabolic activity ensued at every 24 hr time point. This reduced
scaffold dimension, although larger than the 1.05 cm construct, was expected to yield similar
if not better results than the 1.5 cm scaffold from chapter 5. It is not clear as to why such
nominal levels of functionality were exhibited however it is suspected that the seeding flow
rate of 15 ml/min at the scaffold diameter of 1.29 cm was insufficient to induce flow mediated
or forced aggregation.
6.5

Conclusion and Future Work
In this chapter, the effects of increased cell density, via reduced scaffold volume

(30%), was shown to have be beneficial effects on hepatocyte specific functionality,
morphology and viability. The results presented in this chapter also showed that decreasing
the mass transfer distance between the hepatocytes and, the oxygen and nutrient sources
also enhanced the overall longevity of cell health. Because of the information elucidated in
this chapter, the understanding of oxygen uptake kinetics provided by the CFD simulations
and the validated experiments, going forward future experiments should include reduced
scaffold dimensions with high density seeding under seeding and experimental flow rates of
15 ml/min.
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Regarding future work, in order to truly understand and optimize the fluid dynamic
profile within the construct’s micro-environment computational simulations encompassing
100% of the scaffold geometry should be modeled to include the complete fluid trajectory
from the central port inlet to the scaffold outlet. The scaffold geometry should be simulated
with porous media boundary constraints. This will allow the scaffold to be simulated as a
complete porous structure with user specified levels of porosity. The porosity applied to the
mesh geometry should be adjusted to account for the percent porosity of the actual 3D
scaffold as well as the reduced void volume from the entrapped cells. This will aid in
understanding the true pore inlet velocity, back pressure characteristics and the amount of
nutrient and oxygen containing fluid that is actually moving in and through the scaffold. These
parameters, once obtained, should be plugged into the CFD model in chapter 4. This will
give a more accurate understanding of the shear stress imposed on the hepatocytes and the
oxygen consumption kinetics and concentrations with respect to the length of the scaffold.
Coupling this with the appropriate parametric inputs for mesh deformation we can also
estimate which flows rates would provide the best cellular distribution during the seeding
process, while minimizing shear effects and possible cellular washout in culture. Lastly
experimental data detailing nutrient uptake and, protein and metabolite secretion can and
should be incorporated into the model. Coupled together it is hypothesized that such a model
would provide a more accurate and detailed prediction of the microenvironment’s functional
state and aid in future experimental designs.
With respect to the experimental workflow it is my belief that the mechanical properties
of the scaffold should be in-line with that of the liver and the effects of these properties on cell
health and signal transduction should be properly characterized. Additionally more studies
should be conducted to ascertain how phenotypic expression is altered by the current scaffold
configuration but tuned with ECM proteins and concentrations resembling that of the native
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tissue. Lastly studies should be conducted to determine the feasibility of targeted seeding
and culturing of periportal, mid-zonal/transition, and pericentral zone hepatocytes which
would replicate a functional liver lobule within the current scaffold setup. Because oxygen
tensions differ in each zone, additional gas permeable tubing should be incorporated into
scaffold to carry zone specific oxygen tensions which will aid in creating the oxygen gradients
seen in vivo. Once the effects of these efforts are understood co-cultures with sinusoidal
endothelial cells would be the next logical step.
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ABSTRACT
OXYGEN TRANSPORT, SHEAR STRESS, AND METABOLISM IN PERFUSED
HEPATOCYTE-SEEDED SCAFFOLDS WITH RADIAL PORE ARCHITECTURE:
EXPERIMENTAL AND COMPUTATIONAL ANALYSES
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Several modalities have been proposed as treatments or temporary stop-gap for
patients suffering from liver failure until a suitable organ is available. However there is still
an urgent need for an off-the-shelf device that can accommodate clinically relevant cell
numbers, be cultured at physiological oxygen tensions and, can be fully integrated into and
heal the injured hepatic space. In this study we investigated the effects that convective and
direct oxygenation had on hepatocyte functionality, morphology and viability while cultured in
bulk 3D chitosan scaffolds and perfusion bioreactor systems. Cylindrical chitosan scaffolds
with radial directed pore structures were fabricated by a thermal gradient directed from the
center to the periphery. Capillary-like direct oxygenation was facilitated by embedding gas
permeable silicone tubing throughout the scaffold body. Three iterations of bioreactor design
and optimization produced a perfusion system that could enable direct oxygenation,
accommodate high density hepatocyte seeding (8x10-7 to 1x10-8 cells), ensure adequate
mass transfer and induce sustainable metabolic outputs for a least 7 days at a flow rate of 10

186
ml/min. A computational fluid dynamics model of the internal scaffold pore structure infused
with spheroids that resembled hepatocyte aggregates was utilized to understand how varying
flow rates (5, 10, 15, 20 and 25 ml/min) effected fluid flow profiles, shear stress imposed on
the cells and oxygen consumption within the microenvironment. The results showed that the
volumetric flow rate of 15 ml/min at the scaffold’s central port inlet produced the best oxygen
consumption profile with no damaging effects due to shear stress or eddies flow. The
simulation was validated and showed good correlation to empirically derived data.
Experimentally the flow rate of 15 ml/min induced the most favorable hepatic response out of
the five experimental flow conditions and a static culture (only direct oxygenation). We also
looked at how increasing cellular compactness, via reduced scaffold dimensions, would affect
phenotypic expression and viability. It was discerned that increasing the cell packing density
by 14% increased the rate of albumin and urea production by 79% and 40% respectively. In
total the results show that the experimental measures conducted in this study enhanced
hepatocyte metabolic performance, viability and morphological appearance.
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